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CURRENT STATE OF THE AMERICAN HEALTHCARE SYSTEM – WHY 
EXORBITANT SPENDING RESULTS IN LOW INTERNATIONAL HEALTH  
RANKINGS AND HOW TO AMELIORATE THIS PARADOX  
ALICE XIANG 
 
ABSTRACT 
The United States spends more than any other nation on healthcare by an 
exceedingly significant amount. The United States also ranks very poorly on health 
outcomes when compared to other economically developed nations. The reason why the 
United States spends so much more than other nations is because they spend more in all 
categories of healthcare. Hospital admissions and overnight stays are more expensive, 
medical staff salaries are higher than in other nations, procedures and treatments are 
ordered more frequently and cost more than in other nations, prescription drugs prices are 
multiple times greater in the U.S., the multi-payer private and public insurance payment 
schemes are time consuming and complex, and administrative costs are significantly 
higher in the U.S. than in other countries. These complexities and high costs create 
inefficiencies in America’s healthcare system that can interfere with the quality of care 
provided. The major reasons why the United States is lacking in health outcome rankings 
can be attributed to an underdeveloped primary care sector and an underfunded social 
services sector, which make it difficult to coordinate care and practice preventative 
medicine.  
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America’s history of uninsured citizens lacked access to care so the U.S. saw 
repeats of emergency admissions and expensive hospitalizations for chronic conditions. 
These problems are preventable with a more robust primary care sector, increased access 
to care, and advocating public health awareness. Current reforms such as the Affordable 
Care Act are making strides in the positive direction by creating Accountable Care 
Organizations, increasing access to care, and regulating an online insurance marketplace. 
However, continued research and assessments of these new methods of delivering care 
are necessary in the near future to see if pilot studies can be scaled up on a national level.  
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INTRODUCTION 
 
The United States is unquestionably a world leader in healthcare in terms of 
research and academics. Americans have the most advanced technologies to treat patients 
and the potential to provide the best patient care and satisfaction. However, there are 
numerous problems with the United State healthcare system and the most jarring statistic 
is the exorbitant costs of funding medical expenditures. In recent years, about 18% of 
U.S. GDP is spent on healthcare and the spending increases steadily with each passing 
year (World Bank Data, 2015). Other developed nations in Europe spend significantly 
less on their healthcare systems. Among the 34 developed countries that make up the 
Organization for Economic Cooperation and Development (OECD), the United States 
continues to outspend all other nations at a rate of twice the average OECD spending on 
healthcare (OECD, 2011).  
United States High Healthcare Spending 
OECD data from 2010 shows that the United States spent 17.6% of its GDP on 
healthcare while countries like France and Germany spent about 11% of their GDP on 
healthcare and the United Kingdom and Japan spent about 9% of their GDP on healthcare 
(Figure 1). It is also interesting to note that the United States’ public spending only 
accounts for less than half of its total healthcare spending, compared to other countries 
where the majority of healthcare spending is covered by their government. When 
converting the OECD data from 2010 to a quantitative amount per capita, the U.S. spent 
$8,233 per person for healthcare, when the OECD average was about $3,268 per person 
(Figure 2).  
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Figure 1.  Comparison of Percent GDP spent on Healthcare Amongst the OECD Nations in 
2010. Although the U.S. is a very rich country, it devotes far more of its economy to health than 
any other country. The average among OECD countries was almost half that of the U.S., at 9.5 
percent of GDP. Source: OECD Health Data 2012.  
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Figure 2. Comparison of Total Healthcare Expenditure Per Capita Amongst OECD Nations 
in 2010. The U.S. spends over two times greater than the OECD average with $8,233/capita. 
Norway, Switzerland, and the Netherlands are the next highest spenders, but they all spent about 
$3,000/per capita less than the United States  
Source: OECD Health Data 2012 
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United States Poor Health Outcomes 
If the US was ranked number one in healthcare worldwide, this spending might be 
excusable. Unfortunately, according to several studies, the US consistently ranks last 
among first world countries. The World Health Organization (WHO) also ranks the 
United States healthcare at 37-39 worldwide – a much lower number than one would 
expect for the richest nation in the world (WHO, 2000).  
The results show that American health outcomes lag behind many of its European 
counterparts. In the 2013 Institute of Medicine report, Shorter Lives, Poorer Health, the 
United States ranks lower in life expectancy and has higher rates of infant mortality, low 
birth weight, injuries and homicides, adolescent pregnancy and sexually transmitted 
diseases, HIV/AIDS (Human immunodeficiency virus infection and acquired immune 
deficiency syndrome), drug-related deaths, obesity, diabetes, heart disease, chronic lung 
disease and disability than people in other industrialized countries. OECD data from 2009 
demonstrates similar results where the United States ranks much lower in health 
outcomes than other developed nations (Table 1). In addition, this national health 
disadvantage in America is not due to racial and economic disparities. Insured, college 
educated and upper income citizens in the US have poorer health than do their 
counterparts in other industrialized countries (Woolf and Aron, 2013). 
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Table 1. United States Health Outcomes Ranking in Comparison to 34 OECD Countries. 
United States health outcomes such as life expectancy, infant mortality, and low birth weight are 
all significantly worse than other industrialized nations. Source: OECD 2007. 
 
Health	  Outcome	   U.S.	  Ranking	  
Maternal	  mortality	   25th	  
Life	  expectancy	   26th	  
Low	  birth	  weight	   28th	  
Infant	  mortality	   31st	  
Source:	  OECD,	  Health	  at	  a	  Glance	  2007	  	  
 
As these rather indisputable statistics on high costs and comparatively meager 
health outcomes are released, it forces health policy makers and government officials to 
try to understand why their healthcare system has fallen behind. America is entering a 
period of change where they are forced to reassess their current methods, seek successful 
models from other countries, and develop major reforms to improve quality of care, 
access to care, and create more affordable care. In order to begin developing plans to 
improve the current system, one has to first comprehend the American healthcare 
paradox of why spending more is getting less. 
 In order to understand where improvement in America’s healthcare system can be 
accomplished, it is important to first research the ranking criteria. In 2000, WHO created 
its first analysis of the world’s health system, where the organization ranked its 191 
member states by their healthcare systems. The methodology used was based on a series 
of performance indicators to assess the overall level and distribution of population health 
as well as the responsiveness and financing of health care services. More specifically, the 
rankings were based on an index of three factors: Health (50%) – disability adjusted life 
expectancy, Responsiveness (25%) – Speed of service, protection of privacy, and quality 
  6 
of amenities, and Fair Financial Contribution (25%) – cost per capita (Musgrove et al., 
2000). 
American Healthcare Paradox Theories 
Dartmouth economist Jonathan Skinner first used the term ‘paradox’ to explain 
how between 1986 and 2005, the geographic regions with the largest increase in 
Medicare spending were not the ones with the largest survival gains (Skinner et al., 
2006). A number of rationales have been offered to explain this paradox including: 
blaming greedy insurance companies, inefficient and wasteful hospitals and government 
programs, skyrocketing costs of pharmaceutical drugs, expensive hospital overhead and 
administrative costs, and an inadequate attention to an investment in services that address 
the broader determinants of health. Each of these factors is a significant contributor to the 
high costs and will be explored further in this paper.  
Lack of Access  
Additional facets that have been speculated to contribute to America’s mediocre 
to poor health systems include: lack of access to care, fragmentation between public and 
private sectors, medical malpractice, and advancing technologies. However, these culprits 
might not play as significant of a role in rationalizing America’s healthcare paradox. 
Health policy scholars and political leaders often blame lack of access to care to the 
unaffordable high costs of care. They say underinsurance results in poor prevention and 
inadequate adherence to medical recommendations (Schoen et al., 2008). Those that 
believe in this fundamental problem point to the fact that about 25% of the American 
population lacked health insurance as of 2011 (Bradley and Taylor, 2013). Their 
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argument for improvement is to ensure access to preventative and acute care in order to 
improve health outcomes. Providing universal health insurance would indeed improve 
access to needed care, but it would require additional and substantial costs. In addition, 
data suggests that American health outcomes among insured populations still lag 
substantially behind those of other countries (Woolf and Aron, 2013). Thus, reforms such 
as the recent Affordable Care Act (ACA) being implemented in isolation are unlikely to 
resolve the paradox. 
Fragmentation Between Public and Private Players 
Other critics point to the fragmentation between public and private players 
creating inefficiencies in our healthcare system as a primary driver of cost. They also 
point to the lack of primary care resources as a major cause for poor health outcomes. In 
addition, physicians who use a fee-for-service payment arrangement can result in 
unnecessary duplication of medical testing. Those who believe the problem can be 
attributed to fragmented financing systems and the lack of primary care physicians to 
coordinate care have developed health systems known as medical homes. These homes 
are designed to reduce fragmentations and duplication and help individuals navigate the 
health care sector. They are physician-led, team-based health care delivery models that 
seek to provide comprehensive, continuous and well-coordinated medical care (Bradley 
and Taylor, 2013).  
Medical homes implement care coordination services and limit fee-for-service 
reimbursement in favor of various managed care payment schemes, thus reducing 
financing incentives for physicians to provide unnecessary services. However, studies on 
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the effectiveness of these Medical homes have been very ambiguous with many cases 
showing increased spending. The main issue associated with these medical homes is the 
lack of practical methods by which these models can be implemented, replicated, and 
scaled up nationally (Peikes et al., 2009). 
Medical Malpractice Costs 
Some people blame physician medical malpractice lawsuits and insurance plans 
for increasing costs in the healthcare system. They say physician fear of medical 
malpractice compels them to screen for every conceivable disease and use the most 
aggressive treatment available to avoid being sued for not doing everything. In efforts to 
combat high medical malpractice costs, some states have made efforts to reduce this 
problem, but the impact has been largely unimpressive. For example, in 2004, Texas 
conducted what is now referred to as the “failed experiment” (Lincoln, 2011) In an 
attempt for medical malpractice reform, the state capped medical liability expenses. Six 
years later, the state’s health spending per Medicare enrollee rose from seventh to second 
highest in the United States. Private health insurance premiums also rose higher than the 
national average and the percentage of uninsured Texans rose (Bradley and Taylor, 
2013).  
Although the number of medical malpractice payments did decrease considerably, 
the clear beneficiaries of this reform were the insurance companies whose payouts for 
medical malpractice damages were 65% lower, while the premiums paid by physicians 
decreased only 50%. This initiative clearly failed to promote financial savings broadly, 
and the impact on health outcome is unclear (Lincoln, 2011). 
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Sophisticated and Expensive Medical Technologies 
Finally, some blame cultural demands for the most sophisticated medical 
technology as the main driver of cost (Smith et al., 2009). There is undeniable evidence 
that shows America’s high utilization of advanced medical technology is a main reason 
for high costs, but efforts to restrain their use are weak. Once a technology is approved 
for federal reimbursement via Medicare, dramatic increase in its use will be observed. 
Some will argue that advanced medical technologies have allowed for faster and more 
efficient care to decrease length of hospital stays and allow for care in less expensive 
outpatient settings. However, overall medical technology has undoubtedly contributed to 
the national healthcare spending. It also does not help that physicians believe the greater 
use of technology may improve health outcomes, especially if that technology is paid for 
by insurance plans. Current research is being conducted to study the relative cost 
effectiveness of new technologies and pharmaceuticals prior to their large-scale use, but 
reducing the use of technology advancements remains an unlikely solution given the 
current economic, political, and cultural landscape of American healthcare. 
Although policymakers and some practitioners have sought to address these 
problematic downfalls in the health care system, there has not been much success in 
delivering the same level of health per dollar found in other industrialized countries. Past 
reform efforts have tried to lessen the impact of these issues, but none have been 
extremely successful.   
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Purpose of Thesis and Important Questions 
The American Healthcare System is a complex system, and there is no simple or 
single solution to repair its deficits. The majority of Americans and even some 
professionals in the healthcare field are in the dark about how the American healthcare 
system is run and they do not care to delve into its mysteries because of its sheer 
complexity. Both patients and physicians deal with second and third party players like 
insurance companies and administrative staff to deal with payments, so there is very little 
incentive to understand costs. The purpose of this paper is break down some major 
components of the healthcare system in terms so that the average American can begin to 
understand current frustrations that medical professionals and health policy workers are 
experiencing. Although there is no simple solution to mitigating the American healthcare 
paradox, this paper strives to answer the following questions: 
• How does the United States Healthcare system compare to that of other OECD 
nations? How are other nations able to keep costs comparatively low while 
achieving better health outcomes? 
• Why is the United States healthcare system so expensive and how are finances 
actually allocated?  
• Why is there such an enormous gap between spending and health outcomes? 
• What are some potential solutions to ameliorate these problems in the future?   
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COMPARISON TO OTHER COUNTRIES 
 
 Every public health official, health policy maker, and most professionals in the 
medical field are aware of the OECD graphs documenting the high rates of American 
Healthcare spending; additionally, they are aware that United States health outcomes are 
worse compared to other nations. However, they might not be able to point out what in 
particular is costing more than other nations. Unfortunately, there is a complex answer to 
that question because spending in almost every area of healthcare is higher in the United 
States than in other countries. 
Broad Categories of Health Expenditures Among OECD Countries  
 Health expenditure can be broken down into different categories of spending 
including: hospital and nursing home costs, ambulatory care, pharmaceutical costs, and 
public health and administrative costs. Figure 3 compares United States spending with 
other OECD countries that also spend a lot on healthcare, including countries with 
substantial private insurance such as Switzerland, France, and Germany (OECD, 2011).  
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Figure 3. Comparison of Health Spending by Categories of Care Amongst OECD Nations in 
2010. Categories of care include: Hospital/Nursing Homes costs, Emergency Care Costs, 
Pharmaceutical and Medical Goods Costs, and Public Health and Administration Costs. The 
United States outspends othe12r developed countries in every category of care. Source: OECD 
Health 2011 
 
 
Hospital Costs and Medical Provider Salaries 
A 2010 OECD study (Koechlin et al., 2010) found the price of hospital services in 
the United States to be over 60% higher than the average of 12 other OECD countries. 
Spending on Ambulatory care providers – physicians, nurses, technicians, and dentists – 
get paid much higher than in the other OECD countries. Their salaries and their training 
cost almost two-and-a-half times the average of the other five countries. One possible 
explanation for this occurrence can be attributed to the increase of same-day surgery in 
the U.S. These services are an important innovation in health care delivery, and patients 
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appreciate a quick procedure opposed to staying overnight in a hospital. Estimates of 
spending on same-day surgeries performed by independent physicians from 2003 to 2006 
suggests that this has been the fastest growing area of health care over this period 
(Mckinsey Global Institute, 2008).  
The higher costs of hospital care in particular, which accounts for the largest 
percent of healthcare spending, can be partially explained for by services costing more in 
the U.S. When looking across a broad range of hospital services (both medical and 
surgical), the average price in the United States is 85 percent higher than the average in 
other OECD countries (OECD, 2011). To put this in perspective, a hospital stay in the 
United States costs over $18,000 on average. Across OECD countries, the average cost of 
a hospital stay is about one-third that of the U.S., at $6,200 (OECD, 2011). As mentioned 
previously, many OECD countries use strong regulation to set prices hospitals can charge 
for different services, and some even set budgets for how much hospitals can spend total. 
These methods do not hinder the quality of care delivered in hospitals in these countries 
and universities are still able to attract the best students to medicine. 
 Table 2 provides examples of the prices of some common procedures in the 
United States compared with some of the countries with the best quality health systems in 
the world. Looking at specific interventions: -­‐ Coronary bypasses in the United States costs nearly 50 percent more than in 
Canada, Australia and France, and are double the price in Germany. -­‐ The price of a normal delivery in the United States was estimated to be more than 
50 percent higher than in France or Canada, while the price of a caesarean section 
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was 30 percent higher than in France and more than 50 percent higher than in 
Canada.  -­‐ The price of a knee replacement was about 20 percent higher in the United States 
than in France and 50 percent higher than in Canada, while a hip replacement cost 
45% more in the United States than in these two countries.  -­‐ In summary, all of these relatively common medical procedures listed in Table 2 
(appendectomies, baby delivery, hip and knee replacements, coronary surgeries) 
cost more in the United States than other countries with equally high quality 
health systems. 
 
Table 2. Prices for Relatively Common Medical and Surgical Procedures in Countries 
with High Quality Health Care Systems. The cost for the same procedures in the United 
States are more expensive compared to other countries. 
Source: Koechlin et al., 2010 
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 It is difficult to decipher precisely why prices for procedures are almost always 
higher in the United States, but two things are apparent: U.S. physicians are paid higher 
incomes than in other countries and the U.S. uses more expensive diagnostic procedures 
(Kane, 2012). In addition, America’s multi-payer system with numerous different kinds 
of insurance creates huge complexities, providing no one organization to have strong 
incentives to cut out wasteful practices and ensure that all Americans get a good value for 
the very high levels of expenditure incurred for healthcare. 
 Additionally, the United States is known for comprehensive testing, which often 
leads to unnecessary ordering of tests and procedures. Over-testing has become a severe 
and wasteful component that drives up costs. The United States is a leader amongst 
OECD countries in regards to ordering tests and procedures, without actually treating a 
larger number of patients. The U.S. ordered about 90 MRI tests and 230 CT tests for 
every 1000 people in 2010 —twice the average of other OECD countries (OECD, 2011) 
(Table 3). It orders more tonsillectomies and more knee replacements than any other 
OECD country. America also performs more Caesarean sections and coronary bypass 
procedures than in most other countries. 
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Table 3. Frequency of Medical Procedures and Tests Ordered, United States Comparison to 
other OECD Nations. The United States ranks very high in terms of physicians ordering tests 
and procedures such as MRIs, CT Scans, and C-sections. 
Source: OECD Health Data 2011 
 
 
Procedure	   United	  States	  (pop	  =	  
population)	  
Rank	  compared	  
with	  OECD	  
nations	  
OED	  Average	  (pop	  =	  
population)	  
MRI	  units	   25.9	  per	  million	  pop	   2nd	   12.2	  per	  million	  pop	  
MRI	  exams	  ordered	   91.2	  per	  1000	  pop	   2nd	   46.6	  per	  1,000	  pop	  
CT	  scanners	   34.3	  per	  million	  pop	   5th	   22.8	  per	  million	  pop	  
CT	  exams	  ordered	   227.9	  per	  1000	  pop	   2nd	   131.8	  per	  1,000	  pop	  
Tonsillectomy	   254.4	  per	  100,000	  pop	   1st	  	   133.8	  per	  100,000	  pop	  
Coronary	  angioplasty	   377.2	  per	  100,000	  pop	   3rd	   187.6	  per	  100,000	  pop	  
Knee	  replacements	   212.5	  per	  100,000	  pop	   1st	   118.4	  per	  100,000	  pop	  
Caesarean	  sections	   32.3	  per	  100	  live	  births	   8th	   25.8	  per	  100	  live	  births	  
 
The occurrence of these procedures and the use of expensive diagnostic tests all 
depend on physician opinion on whether the patient should receive them or not. 
American physicians decide that more procedures and tests are desirable compared to 
their peers in other countries. Mark Pearson, head of Division on Health Policy at OECD, 
offers a few explanations for this phenomenon. First of all, American physicians are 
taught to have a fear of litigation. They order extra tests and comprehensive screening to 
cover themselves in case a patient decides to sue for malpractice. This forces physicians 
test for everything so that they cannot be blamed for not having covered all their bases, 
thus keeping their malpractice insurance premiums as low as possible. Secondly, many 
hospitals and health clinics use a fee-for-service policy where physicians receive 
payments for ordering or performing more interventions, regardless of medical necessity. 
Thirdly, patients themselves tend to be more satisfied if they receive more tests and 
services. They feel comforted to know that medical problems are being diagnosed or 
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treated, regardless of whether they are medically necessary. It does not help that all these 
services and test are often paid for by insurance policies, so the immediate cost of extra 
treatment for a patient is often zero or very low (Kane, 2012). 
Other OECD countries avoid this problem of over-treating by investing in 
creating national ‘clinical guidelines’ to promote a more rational use of MRI (magnetic 
resonance imaging) and CT (computed tomography) exams. In the United Kingdom, 
since the creation of the Diagnostic Advisory Committee by the National Institute for 
Health and Clinical Excellence (NICE), a number of guidelines have been issued on the 
appropriate use of MRI and CT exams for different purposes (Kane, 2012).  
Pharmaceutical Drugs and Medical Equipment  
 Spending on pharmaceuticals and medical goods is also higher in the U.S. than in 
any other country. Again, cost for pharmaceutical drugs exceeds costs in other countries 
by over two times (OECD, 2011). The major reason why drugs in America cost more 
than the exact same drugs in other countries is because of American pharmaceutical 
company patents products that then allows the company to control costs. In other 
European nations, government regulation can cap prices on drugs to contain costs 
(OECD, 2011). This type of regulation does not exist in the United States and corporate 
pharmaceutical companies would most likely deem such strict regulation as 
unconstitutional.  
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Public Health and Administration Costs 
 Finally, spending on Public Health and Administration is particularly high in the 
United States – more than two-and-a-half times the average (OECD, 2011). In the U.S., 
nearly $900 per person per year goes towards administrative costs. This is three times 
higher than France, which only spends $300 per person on administrative costs, despite 
having a system in which health care services are reimbursed in a similar way to the U.S. 
Similarly, systems such as Switzerland and Germany also have multi-payer systems, yet 
their spending on administration is less than half that of the United States. In comparison, 
Canada and Japan are countries that do not utilize multi-payer insurance systems and 
these countries devote significantly less spending on administration personnel (Kane, 
2012).  
Part of the problem of why Administrative costs in the U.S. are higher is because 
the U.S. has been slow to embrace the advantages of information and communications 
technology in improving the administration of its system and in cutting down on waste. 
In Sweden, for example, all drug prescribing is done electronically — a message is sent 
directly from the doctor’s office to the pharmacy (Kane, 2012). Not only does this cut 
down on medical errors, but also aids pharmacists in being more efficient. In recent 
years, the Affordable Care Act will require a complete conversion of patient paper files 
into electronic files and many doctors in America are also switching to electronic 
prescriptions. However, this is an ongoing and tedious process that not all American 
physicians agree with.  
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Where the United States Does Less than other OECD Countries 
 
On the other hand, Table 4 shows where the United States does less than other 
OECD countries (OECD Health Data 2011). The U.S. has fewer physicians and less 
physician consultations relative to its population. The U.S. also has fewer hospital beds 
for its population size and shorter average stays in hospital relative to other countries. 
The lower numbers of physicians could definitely help explain why they receive much 
higher salaries; there is less competition for patients. 
 
Table 4. Where The United States Underperforms other OECD Countries. The United States 
on average has fewer physicians, less hospital beds, and shorter hospital stays compared to other 
OECD nations. Source: OECD Health Data 2011 
 
	   United	  States	  (pop	  =	  
population)	  
Ranke	  compared	  
with	  OECD	  nations	  
OECD	  Average	  (pop	  =	  
population)	  
Practicing	  physicians	   2.4	  per	  1000	  	   26th	   3.1	  per	  1000	  pop	  
Doctor	  consultations	   3.9	  per	  capita	   29th	   6.5	  per	  capita	  
Hospital	  beds	   3.1	  per	  1000	  pop	   29th	   4.9	  per	  1000	  pop	  
Hospital	  discharges	   130.9	  per	  1000	  pop	   26th	  	   158.1	  per	  1000	  pop	  
Average	  length	  of	  stay	  
in	  hospitals	  
4.9	  days	   29th	  	   7.2	  days	  
 
Having fewer hospital beds and shorter hospital stays can be considered 
beneficial. Fewer hospital beds could signify that wasteful overuse of hospitals is being 
avoided in the U.S. system. Medicare in the U.S. has pioneered how hospitals are paid – 
this government insurance provides a fixed amount for a patient with a particular 
condition, which means that hospitals have an incentive to treat patients as quickly as 
possible (Kane, 2012). The data from Table 4 depicts where the United States does less 
compared to OECD countries should suggest that U.S. health spending should be low 
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compared with other countries (OECD Health Data 2011). America does more of some 
activities such as testing and procedures, but less of others such as number of physicians 
and hospital beds. Therefore, higher prices are the more relevant and important cause of 
high spending.  
Commonwealth Fund 2014 Assessment of International Healthcare  
The Commonwealth Fund is another organization that has large investments in 
understanding health systems and promoting high standards of care. The Commonwealth 
Fund’s 2014 report studies how the United States care system compares internationally 
(Davis et al., 2014). This report takes a closer look at 11 countries including: Australia, 
Canada, France, Germany, Netherlands, New Zealand, Norway, Sweden, Switzerland, 
the United Kingdom, and the United States. This report ranks each nation based on 
Quality, Access, Efficiency, Equity, and Healthy Lives. It incorporates patient and 
physician survey results on ratings for care experiences, medical practices and views on 
their countries health systems. 
According to the Commonwealth Fund’s report, the most obvious way that the 
United States differs from other industrialized countries is the absence of universal 
healthcare (Table 5)(Davis et al., 2014). This is a major reason why the U.S. 
underperforms in statistics regarding access and equity between populations. The U.S. is 
also lacking in other measures such as health outcomes, quality, and efficiency of care. 
Physicians in the US have reported difficulties in receiving timely information, 
coordinating care, and dealing with administrative hassles. Unlike other countries, the 
U.S. has been slow in adapting modern health information systems. However, the 
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Affordable Care Act will ensure this transition for the purpose of efficient organization 
and delivery of health care (Davis et al., 2014). Although there is always room for 
improvement in every nation, there is a considerably larger problem for the United States. 
Some of the major findings of this study focused on Quality, Access, Efficiency, Equity, 
and Healthy lives:  
 
Quality: Four categories were assessed for quality of care – effective care, safe care, 
coordinated care, and patient-centered care. Compared with the other 10 countries, the 
U.S. ranked higher at provision of patient-centered care. However, lower scores on safe 
and coordinated care pull the overall U.S. quality score down. Gradual and continued 
adoption of health information technology should enhance the ability of U.S. physicians 
to better identify, monitor, and coordinate care for their patients, particularly those with 
chronic conditions (Davis et al, 2014). 
 
Access: Given the previous absence of universal coverage, people in the U.S. do not seek 
needed health care due to the extraordinary costs of care that are unseen in nations with 
universal healthcare. Although patients in the United States have rapid access to 
specialized health care services, they are less likely to report rapid access to primary care. 
In other countries, like Canada, patients have little to no financial burden, but experience 
wait times for specialized services. There is a frequent misperception that trade-offs 
between universal coverage and timely access to specialized services are inevitable; 
however, the Netherlands, the United Kingdom, and Germany provide universal coverage 
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with low out-of-pocket costs while maintaining quick access to specialty services (Davis 
et al., 2014). 
 
Efficiency: On indicators of efficiency, the U.S. ranks last among the 11 countries, with 
the U.K. and Sweden ranking first and second, respectively. The U.S. has poor 
performance on national health expenditures and administrative costs as well as on 
measures of administrative hassles, avoidable emergency room use, and duplicative 
medical testing (Davis et al, 2014).  
 
Equity: The U.S. ranks a clear last on measures of equity. Americans with below-
average incomes were much more likely than their counterparts in other countries to 
report not visiting a physician when sick; not getting a recommended test, treatment, or 
follow-up care; or not filling a prescription or skipping doses when needed because of 
costs (Davis et al, 2014). 
 
Healthy Lives: The U.S. ranks last overall with poor scores on all three indicators of 
healthy lives—mortality amenable to medical care, infant mortality, and healthy life 
expectancy at age 60 (Davis et al, 2014).  
 
Overall, the United States ranks last among these 11 OECD nations, with 
particularly low scores in efficiency, equity and outcomes (Davis et al., 2014) (Table 5 
and Figure 4). The United States ranks high on preventive care, and has short waiting 
times for specialist care, but they scored low on access to needed services and they have 
  23 
difficulty obtaining care from primary care physicians. These rankings summarize 
evidence based on national mortality data and the perceptions and experiences of patients 
and physicians. 
 
 
 
Table 5. The Commonwealth Fund Healthcare Rankings of Developed Countries Based on 
Quality of Care, Access to Care, Efficiency of Care, Equity of Care, and Healthy Lives 
Outcomes. The United States ranked poorly for Efficiency, Equity, Health Outcomes, and 
Access. The United States’ Healthcare Overall ranking is last among these 11 industrialized 
nations.  
Notes: Expenditures shown in $US PPP (purchasing power parity) 
Source: Davis et al., 2014 
 
 
  24 
 
Figure 4. The Commonwealth Fund’s Rankings of 11 Developed Nation Healthcare Systems 
in 2013. The United States received the overall lowest score while nations like the United 
Kingdom and Switzerland received the highest scores. Source: Davis et al, 2014 
 
Disparities in access signal the need to expand insurance coverage. Under the 
Affordable Care Act, low- to moderate-income families will be eligible for financial 
assistance in obtaining coverage. Concurrently, the U.S. has accelerated the adoption of 
health information technology and U.S. providers are encouraged to utilize integrated 
medical records that are accessible to providers and patients. These efforts will likely 
help clinicians deliver more effective and efficient care. According to this 
Commonwealth fund report, some things the U.S. can learn from other countries include: 
public reporting of quality data, payment systems that reward high-quality care, and a 
team approach to management of chronic conditions (Davis et al., 2011). 
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Where the United States Outperforms other Nations 
Despite all the inefficiencies and high costs of American health care while 
receiving comparatively poor health outcomes, there are some aspects of America’s 
healthcare system that out performs other countries. If insured, waiting times for U.S. 
patients are among the lowest in OECD countries. Patients in the United States also 
benefit from better cancer outcomes. OECD Health Data shows that the five-year 
survival rate for breast cancer is higher in the U.S. than in other OECD countries; 89.3 
percent compared to an OECD average of 83.5 between 2004 and 2009 (OECD, 2011). 
Survival from colorectal cancer is also among the best; 64.5 percent compared to an 
OECD average of 59.9 percent, 2004-09 (OECD, 2011). The quality of acute care in 
hospitals is generally good in the United States, compared with other OECD countries. 
In-hospital case fatality for myocardial infarction and ischemic stroke is also lower than 
the OECD average (OECD, 2011).  
Most obviously, the U.S. leads the world in health care research. The Food and 
Drug Administration’s (FDA) comparatively shorter drug approval processes means that 
cutting-edge drugs and treatments are available more quickly to American patients than 
elsewhere. The U.S. is also trialing more new procedures and treatments, with the 
National Institutes of Health currently registering 119,469 clinical trials underway in the 
U.S., vastly more than any other OECD country (Kane, 2012). 
Although net healthcare spending increases annually, the rate of growth has been 
on a significant slowing trend. This is primarily due to price changes in the 
pharmaceutical and hospital sectors. The slowdown has been gradual and decelerated to 
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around 2 percent in 2011 and 2012. This lower growth rate remains higher than the 
OECD average, which includes some European countries that made significant 
reductions in health spending (OECD Health Statistics 2014 )(Figure 5). 
 
 
 
Figure 5. Health Expenditure Growth Rate Trends – The United States and OECD 
Averages. Although the net spending on healthcare grows each year in every nation, OECD data 
shows that the growth rates are actually decreasing. OECD average growth rate has declined 
more steeply than United States growth rates. 
Source: OECD Health Statistics 2014 
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HISTORY OF AMERICAN HEALTHCARE 
 
 Besides assessing the current state of America’s healthcare system, the historical 
perspective of America’s healthcare sector demonstrates how it evolved to be this way 
and it allows the public to understand the potential impediments to reform. The 
professionalization of medicine and the emergence of insurance companies has been a 
long and gradual process. Several previous Presidents have developed blueprints for 
healthcare reform with varying degrees of success. This section explores the growth of 
healthcare in America from its colonial days throughout the twentieth century.  
Development of American Healthcare Sector: Colonial Era to Twentieth Century 
From the colonial era until the early 1800s, healthcare in America was terribly 
unorganized and unfounded on scientific basics. Physicians practiced procedures such as 
bloodletting to restore balance in the body. Sweating, urinating, defecating, and vomiting 
were all believed to be pathways by which a patient could restore balance and remove 
toxins. Thus treatments often included laxatives and other purgatives, which are now 
known to worsen the condition and leave blisters in the body. Medicine at this time 
included poisons such as mercury, which was used for the treatment of syphilis. When 
Jacob Bigelow from the Harvard Medical School studied medicine in Paris in 1835, he 
said: “[It is] the unbiased opinion of most medical men of sound judgment and long 
experience that the amount of death and disaster in the world would be less, if all disease 
were left to itself.” (Bradley and Taylor, 2013). 
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Even in the early 1900s, hospitals were regarded poor and even dangerous. If one 
could afford treatment at home, that was much preferred opposed to hospitals that housed 
the destitute, mentally ill, outcasts, paupers, and runaways. The major hospitals were in 
urban areas such as Boston, Philadelphia, New York, New Orleans, and St. Louis. Most 
people paid out of pocket for medical attention during this time (Bradley and Taylor, 
2013).  
Louis Pasteur’s development of germ theory led to major changes in the latter half 
of the 1800s. With public acceptance of Pasteur’s germ theory, people learned that 
microbe sized life forms were to blame for illness, rather than evil spirits or an imbalance 
of bodily humors. By identifying the correct culprit for disease, progress for defeating 
disease could occur more quickly. Concurrent technological advances and major 
educational reforms also elevated the prestige and impact of medical doctors and 
surgeons.  
In the earlier years, physician education relied on apprenticeship models. Many of 
the students pursing apprenticeships to become a physician had not completed high 
school. In the late 1800s, large-scale medical reforms would change the standards of 
medical education to an elevated level of prestige. Medical schools began affiliating with 
hospitals, a college degree became a prerequisite for admission, and high standards for 
curricula were developed. With more stringent standards, the number of medical schools 
dropped precipitously from 160 in 1904 to only 66 in 1935 (Zinner and Loughlin, 2009). 
Concern over the state of American medicine gave rise to a marked influx of 
philanthropy to medical education across the country from both private donors and state 
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governments.  By the 1920s, economic prosperity and tremendous scientific progress 
increased America’s faith in and demand for physician services. Over the course of half a 
century, medicine went from being a poor, underappreciated craft to a now lucrative and 
prestigious profession. Hospitals were transformed from a place of filth, danger, and 
poverty to a place of cleanliness, order, and optimism (Zinner and Loughlin, 2009). The 
discovery of penicillin in 1928 and the rise of sulfa drugs in the 1930s bolstered the 
ability to manage disease. Successful drugs and surgeries brought physicians middle class 
clientele and reasonable compensation, and thus American medicine began to emerge as 
an effective and even profitable industry.  
The century between the end of the Civil War and the beginning of the civil rights 
movement saw hospital use increase 200 fold while the population increased 5 fold. 
Healthcare infrastructure expanded markedly during the 1900s. The Hill Burton act of 
1946 provided major expansion money from the federal government to increase hospital 
beds, and by the late 1960s, the number of people admitted to a hospital each year was 
more than 29 million (Porter, 1998). By 2010, 80% of adults in the US had seen a doctor 
in the past year with the average number of visits being 3.8 times a year (Bradley and 
Taylor, 2013). Fueled by increasing demand for valued services, the United States health 
care industry – medical treatment, mental health care, life sciences and pharmaceuticals, 
and nursing homes – is now the largest industry in the world. 
Emergence and Development of American Medical Insurance Companies 
The beginning ideas of health insurance came about in the 1930’s. Justin Ford 
Kimball, vice president at Baylor University developed the first system that can be 
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recognized as modern American insurance (Cunningham and Cunningham, 1997). He 
noticed that the Baylor University hospital had many unpaid bills, particularly by 
teachers in the university systems in Dallas, Texas. When faced with the declining 
revenues due to the Great Depression, Kimball developed a payment scheme to bolster 
the financial stability of the university (Cunningham and Cunningham, 1997). The 
Kimball plan was unique because it not only covered work-related accidents and 
disability, but it also covered any hospitalization expenses incurred at Baylor Hospital. 
For a prepaid premium of six dollars a year, the plan guaranteed payment for up to 21 
days of hospital care at Baylor Hospital. Kimball’s plan was a success on a local level 
and attracted national attention, which inspired several similar plans to emerge around the 
country (Cunningham and Cunningham, 1997). In 1937, the American Hospital 
Association (AHA) consolidated a group of nonprofit plans that met certain standards, 
and choose 38 plans covering more than one million Americans as the newly formed 
Blue Cross network.  
The concept of insurance for physician services, opposed to hospital care, first 
appeared in the lumber and mining camps of the Pacific Northwest.  Employers wanted 
to provide medical care for their workers so they paid monthly fees to a bureau that 
comprised a group of physicians. These pioneer programs led to the first Blue Shield 
Plan, which was established in California in 1939 to cover physician services 
(Cunningham and Cunningham, 1997). In 1982, the Blue Cross Association and the 
National Associated of Blue Shield Plans merged to form the modern Blue Cross Blue 
Shield Association.  
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While Americans were demonstrating characteristic entrepreneurship in providing 
insurance on a local level throughout the early 1900s, European countries were 
developing or had developed national, compulsory insurance plans that were planned and 
managed by their central government. Germany led the way in 1883 with national, 
compulsory sickness insurance with government-subsidized funds. Although the plan was 
originally developed for low-income citizens and government workers, it had expanded 
to include the entire population by 1950. Other nations followed the German example of 
universal health insurance, including Austria in 1888, Hungary in 1891, Denmark in 
1892, Norway in 1909, Britain in 1911, and the Netherlands in 1913 (Flora and 
Heidenheimer, 1981). By the 1970s, Germany, the United Kingdom, Sweden, Canada, 
France, and Italy all had compulsory public insurance programs for industrial accidents, 
pension insurance, unemployment insurance, family allowances, and health insurance.   
In 1917, president Theodore Roosevelt supported comprehensive public 
insurance, including compulsory health insurance because he believed the country could 
not be strong if people who fell ill were made poor on account of growing medical 
liabilities (Bradley and Taylor, 2013). The United States entry into WWI in 1917 created 
anti-socialist sentiments, so national health insurance became inconsistent with American 
values. Post war fears of communism further suppressed any remaining interest in 
compulsory insurance by hopeful Progressive Party members.  
However, the onset of the Great Depression reopened up the discussion for 
universal healthcare as an increasing number of people struggled to afford medical care. 
The American Medical Association (AMA) firmly opposed any government control of 
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medical care, particularly through financing of physician work (Bradley and Taylor, 
2013). The AMA appealed to the national ideology of individualism and focused on the 
fact that expanded government involvement in healthcare would be unaffordable to argue 
against universal health insurance. By 1950, lobbying efforts from the AMA stated that 
national health insurance would make doctors “slaves” and linked national insurance 
plans to communism and socialism (Starr, 1982).  
WWII and the cold war era further discouraged the country from desires for 
federal provision of health insurance. Fears of socialism fueled American skepticism of 
government expansion. Employer based insurance schemes began to emerge as viable, 
privatized alternatives. The offer of medical insurance to employees began as an 
innovative and effective method of attracting workers. Given the rising expenses of 
medical care, employees gladly accepted employer-paid health insurance in lieu of salary 
increases. Congress amended the Internal Revenue Code to make employer-sponsored 
health insurance tax exempt and health insurance could be bargained as part of the union-
employer contracting. The private insurance market has grown tremendously from $1 
billion in 1950 to $848.7 billion in 2010 (Bradley and Taylor, 2013). With this eight 
hundred fold increase in private insurance in the past 60 years, the notion of employer 
based health insurance has become entrenched in American society. 
In 1965, the largest government-run health insurance programs were signed into 
law, known as Medicare and Medicaid. Both conservatives and liberals supported the 
Medicare program, which was a federally funded and government-administered program 
to provide health insurance for older adults. Medicaid and Medicare were funded both by 
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national and state governments, but administered by the states. This insurance was 
designed to protect people with low incomes who met state-specific categories (pregnant 
women, blind, disabled, etc.). While health care spending was increasing steadily from 
1935-1965 before Medicare and Medicaid (from 4 to 5.7 percent of GDP), spending blew 
up in the three decades after by 140.4% (from 5.7 to 13.7 percent GDP) (Bradley and 
Taylor, 2013). This growth was first fueled by improvements in medical education, then 
by an enormous expansion of hospital beds, and finally by major funding for the 
Medicare and Medicaid government insurance programs.  
This explosion of healthcare costs captured political attention in the 1970’s, 
propelling President Nixon to seek methods to restrain costs without compromising 
quality or access. Nixon recruited experts to develop a model to improve health of a 
defined population at a reasonable cost. Eventually they developed the Health 
Maintenance Organization (HMO) or the HMO Act of 1973. This HMO model allows 
employees to pay into a plan and obtain their medical care from the physicians that the 
insurance plan employs. HMO covers care by doctors and other professionals who have 
agreed by contract to treat patients in accordance with the HMO's guidelines and 
restrictions in exchange for a steady stream of customers. 
 The reason why HMOs were more cost effective is because the plan could 
oversee and approve physician decisions such as whether to admit a patient, how long to 
keep the patient in the hospital, and whether to order expensive diagnostic tests for the 
patient. Normally, physicians made these decisions autonomously. The HMO “managed” 
care, with the goal of limiting high costs, without compromising patient outcomes. In the 
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next three decades, health insurance plans adopted tactics introduced by the HMO model 
to limit expenditures and health care use. Managed care grew to encompass 97% of the 
employer-sponsored health insurance market, which represents approximately half of all 
insured Americans (Bradley and Taylor, 2013). Since the managed care systems lowered 
costs, Medicare and Medicaid programs also began to increase their managed care tactics, 
instituting greater control over physician and hospital decision-making, to further 
rationalize their spending. Thus, managed care efforts began to slow the acceleration of 
health care costs during the 1990’s; however, this attenuation could not be sustained. 
Public complaints of overly harsh rationing by managed care companies reduced their 
popularity in the employer insurance market and cost acceleration resumed in the early 
2000’s. 
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CURRENT SPENDING 
 
Thus far, the discussion on expensive healthcare has mostly been focused on net 
expenditures, percentage GDP, and per capita spending. Spending allocations have been 
briefly mentioned in an OECD report, but this section looks at domestic data on where 
American dollars are divided in healthcare. The Center for Disease Control and 
Prevention (CDC) gathered National Health Statistics data on a great variety of health 
measurements in the United States. Highlights of the report include: national health 
expenditures, percent distribution, and percent annual change by type of service.
 National health expenditure can be broken up into two major categories: Health 
Consumption and Health Investment.  Health consumption includes expenditures such as 
hospital care, physician and clinical professional services, nursing facilities, prescription 
drugs, medical equipment, government administration, health insurance, and government 
public health activities. On the other hand, investment in healthcare is mostly related to 
research and technologies that develop new treatments and more advanced equipment. 
United States data gathered from 2011 estimates the net spending of healthcare was 2.7 
trillion dollars (CDC, 2013). When studying Table 6, it is apparent that the largest 
percentage of spending goes towards hospital care (31 percent, 850 billion dollars), and 
professional services (26 percent, 723 billion dollars). Another factor that stands out as 
particularly high is the cost of prescription drugs, which accounts for 9.7 percent of the 
total healthcare spending, at about 263 billion dollars. Government does not play a major 
role in regulating healthcare so government administration only accounts for 1.2 percent 
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of the spending or 32 billion dollars. Although research in the United States is at the 
forefront of innovation, America only spends about 1.8 percent of their healthcare dollars 
on research.  
 
Table 6. United States Health Expenditures in 2011 – U.S. Dollars and Percent Distribution. 
In 2011, the United States spend 2.7 Trillion dollars on healthcare with the majority of 
expenditures towards Hospital Care and Professional Services. A much smaller percentage of 
spending (less than 2%) went towards Government Administration and Research.  
Source: CDC: United States Health Statistics, 2013. 
 
 In addition to understanding the distribution of American healthcare dollars, CDC 
data also shows that healthcare spending is growing at a decreasing rate. From 1980 to 
2011, per capita spending on healthcare has grown from 256 billion to 2.7 trillion. 
Although net spending on healthcare increases annually, the percent change from 
previous years is decreasing. From 1980 to 2011, the percent change in healthcare 
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spending had decreased from 13.1 to 3.9 percent and continues to slow at the lower rate 
of 2 percent growth in recent years (CDC, 2013).   
 Finally, who pays for America’s healthcare? There are different methods of 
payment including out-of-pocket payments, private insurers, government insurance like 
Medicare and Medicaid, and other federal, state and local programs. According to the 
United States 2013 Health Report, 13 percent of health payments were ‘Out-of-Pocket’ 
expenditures while 78.1 percent were paid by insurance companies: 34 percent by private 
insurance companies, 23 percent by Medicare, and 16 percent by Medicaid (CDC, 2013). 
The other 8.4 percent were from other third party payers and programs – most likely from 
donations or fundraising (Table 7).  
 
Table 7. United States Health Expenditures from 1960 – 2011: Annual Percent Change from 
Previous Year Shown. Although total spending on healthcare has continuously increased, the 
rate of spending growth has declined in recent years.  
Source: CDC: United States Health Statistics, 2013. 
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 Despite the high costs of hospitals and medical professionals, the high cost of 
pharmaceutical drugs is declining rapidly in recent years. The annual growth in spending 
on retail prescription drugs slowed from 14.7% in 2001 to 2.9% in 2011. The growth in 
spending on prescription drugs was in the double digits from the mid-1990s through the 
mid-2000s, when it fell below 10% (Figure 6). This recent slowdown is the result of a 
variety of factors, including cost control efforts introduced by insurers, such as copays, 
formularies, tiered pricing, generic substitution, and the use of mail order pharmacies. In 
addition, several popular drugs ended their patent protection during this time frame (U.S. 
Health Report, 2013). 
 
Figure 6. Retail Prescription Drug Expenditures, Annual Percent Change, and Spending by 
Payer: United States, 2001 – 2011. Retail drug prices have increased from 138.7 billion in 2001 
to 263 billion in 2011. However, the annual percent increase in drug prices has been decreasing 
over this ten year time period.  
Source: CDC, United States Health Statistics, 2013 
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Starting in 2014, spending is expected to pick up due to expanded insurance 
coverage as a result of the Affordable Care Act (ACA) and because fewer drugs are 
expected to lose patent protection in 2013 compared with 2012. 
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PHARMACEUTICAL DRUG COMPANIES 
 
The United States spends substantially more per capita on prescription drugs than 
other members of the OECD. The Commonwealth Fund supported a research study that 
examined variation in drug prices among selected OECD countries in three years (2005, 
2007, and 2010) to determine which nations paid the highest prices for brand-name 
drugs, to identify variations in per capita drug spending, and to isolate the factors 
contributing to drug spending rate increases (Kanovos et al., 2013). The study examined 
prices and spending for brand-name drugs in Australia, Canada, France, Germany, 
Switzerland, the United Kingdom, and the United States. 
Costs of Prescription Drugs are Highest in the United States  
OECD data from the past decade show that total prescription drug spending per 
capita rose significantly in Canada (84 percent between 2000 and 2010), the United 
States (81 percent), and Germany (79 percent). Other countries showed smaller increases 
(Figure 7). The United States had the highest level of per capita spending on prescription 
drugs in 2010 of the countries in this study—more than double that of the United 
Kingdom, the lowest spender. Prices for brand-name drugs were 5 percent to 117 percent 
higher in the U.S. than in the other countries in all three study years (Kanovos et al., 
2013). These differences may not reflect price discounts negotiated by U.S. insurance 
companies. 
In addition, taxes are traditionally higher in other countries than in the United 
States, thus reducing the differences in drug prices between the United States and other 
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countries. The effect of taxation can be considerable. For example, the value-added tax 
on prescription drugs is 19 percent in Germany but only 2.1 percent in France. Australia 
and the United Kingdom do not have any value-added tax on prescription drugs 
(Kanovos et al., 2013). 
 
 
 
 
Figure 7. Total Pharmaceutical Spending per Capita in Seven Countries, 2000 and 2010. 
The United States leads in spending per capita on pharmaceutical drugs by a significant amount. 
The United States and Canada saw the highest increases in drug spending from 200 to 2010. 
Source: Kanovos et al., 2013 
 
According to Kanovos et al. (2013), one of the key differences between the 
United States and other countries was that new medical products are introduced faster 
and have more intensive use in the United States. Differences in the introduction and 
distribution of new products may be attributed to the way value was assessed in different 
countries. Most countries in the study have regulatory agencies to assess the value of new 
medicinal products in terms of clinical benefit and cost-effectiveness. In the United 
States, the Patient-Centered Outcomes Research Institute (PCORI) examines the relative 
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health outcomes, clinical effectiveness, and appropriateness of different medical 
treatments, but not their cost (Kanovos et al., 2013). 
Differing pricing practices among the various countries in the study may also 
explain why the United States and Canada had the largest price increases over time. 
European countries and Australia use regulatory price setting, which makes it difficult—
if not impossible—to change prices over time. In the United States, there is no agency 
that governs price increases for existing products.  
In conclusion, this Commonwealth Fund study believes that U.S. policymakers 
could consider requiring drug makers to provide more evidence about the value of new 
drugs relative to their cost, as other OECD nations do. Evidence of cost-effectiveness 
could be one of the criteria used in determining which patients are likely to benefit from 
individual drug therapies. Other approaches, such as price modulation (manufacturers 
raise prices for some drugs—often the newer products—while lowering prices for others) 
could be used to control spending while encouraging uptake of innovative new therapies 
(Kanovos et al., 2013). 
History and Future of American Pharmaceutical Companies 
David Belk, a practicing internal medicine physician who works in the San 
Francisco Bay Area provides his research and anecdotal experiences through his website, 
“The True Cost of Healthcare” (True Cost of Healthcare, 2014). He provides insightful 
and relatable stories that allow medical and non-medical professionals to understand the 
frustrations with cost and lack of transparency in the American healthcare system. Belk 
acknowledges how the U.S. spends significantly more on prescription drugs than other 
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countries, but he also offers an explanation for why drug prices are expected to drop in 
the future.  
 The Golden Age for pharmaceutical companies lasted from the 1970’s to the mid 
1990’s, when dozens of new medications changed the way doctors practiced medicine. 
Medications for heart disease and diabetes prolonged the lives of patients by years or 
even decades. New classes of oral antibiotics were more effective than the drugs that 
previously could only be administered in the hospital, so patients with severe infections 
could be sent home with pills. The golden age drew to a close in the 1990’s when the 
pharmaceutical companies began to tire of new ideas. New ideas are always expensive 
and risky and even the most brilliant sounding ideas were unsuccessful when tested 
clinically (Belk, 2014). 
Although pharmaceutical company profits remained high, barely any new 
products were being created. In 2003, most of the prescription medications were still 
under patent, but several patents were lost in 2011 and 2012. The effect is easy to see in 
the following graph, which shows the dramatic loss of revenue when the patent Bristol-
Myers Squibb owned on Plavix expired. United States yearly revenue from Plavix sales 
plummeted in 2011, and now costs about the same as it does in other countries (Figure 8) 
(Belk, 2014). 
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Figure 8. Pharmaceutical Company, Bristol-Myers Squibb’s, Yearly Revenue from Plavix 
Drug Sales, 2006 – 2013. Bristol-Myers Squibb lost their patent for Plavix in 2011, which caused 
them to loose over $6 billion dollars a year just from the United States. Source: Belk, 2014 
 
 
A New York Times article also explains how Pfizer lost its 10-billion-a-year 
revenue stream when the patent on its blockbuster cholesterol drug Lipitor expired and 
cheaper generics began to cut into the company’s huge sales (Wilson, 2011). The loss 
poses a daunting challenge for Pfizer, one shared by nearly every major pharmaceutical 
company. In 2011 alone, because of patent expirations, the drug industry lost control over 
more than 10 mega-medicines whose combined annual sales have neared $50 billion 
(Wilson, 2011). This is a sobering reversal for an industry that was the world’s most 
profitable business sector just a few years ago. This challenge casts a spotlight on the 
problems drug companies now face: a drought of big drug breakthroughs and research 
discoveries; pressure from insurers and the government to hold down prices; regulatory 
vigilance and government investigations; and thousands of layoffs in research and 
development. Drug companies cut 53,000 jobs in 2010 and 61,000 in 2009, far more than 
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most other sectors  (Wilson, 2011). Several drug companies have also been bought out or 
were forced to merge.  
As companies move beyond the blockbuster drug model, they are refining their 
approach toward personalized medicines. Instead of selling new drugs to millions of 
people, the new plan is to use genetic or other patient specific tests, to provide treatments 
for those who would most clearly benefit (Wilson, 2011). Nevertheless, the industry faces 
intense pressure from generic competition and has tried every tactic to ward it off. They 
have instituted a number of measures to help offset the amount they have been losing to 
lost patent protection.  
They have fought to effectively delay the expiration of drug patents whenever 
possible. For example, they can apply for a new indication for an old drug just prior to 
patent expiration. They can change the delivery system to, say, an inhaler. They can alter 
the recommended doses of a drug by a small amount, they can create a pill that combines 
two ingredients-- they have many tricks for delaying patent expirations and these tricks 
can often delay a patent expiration for several years.  In 2013, the pharmaceutical 
companies convinced the U.S. Supreme Court to allow them to pay generic drug makers 
to delay the release of generic equivalents of medications for a time after the patent for a 
medication expires (Belk, 2014). In addition, they have substantially raised the prices of 
currently patented medications. Table 8 shows the average price pharmacies paid for 
medications for which there is no available generic equivalent yet. It shows the average 
cost for these medications in October 2012 compared to the average cost for the same 
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medications in May 2014. In just 19 months most of the listed medications increased 20-
30% in price (Belk, 2014). 
Table 8. Select Medication Prices in the United States that Increased from 2012 to 2014. 
Pharmaceutical companies increased the prices of their prescription drugs significantly before the 
drug patents will expire.  Source: Belk, 2014 
 
 
 
Drug industry lobbyists have beaten back Democratic proposals to set prices at 
the lower levels of nations like Canada or to allow Medicare to directly negotiate prices. 
President Obama’s health care reforms contain new laws that could pose major threats to 
drug industry profits by allowing centralized price-setting. Beginning in 2015, an 
independent board appointed by the president could lower prices across the board in 
Medicare unless Congress acted each year to overrule it (Belk, 2014). In addition, 
managed care and government health programs are urging pharmaceutical companies to 
cut prices and improve reimbursement terms for their most profitable pills. This follows 
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similar practices in Europe, where Germany and the Britain, among other countries, are 
all increasing pressure for lower drug prices (Wilson, 2011). 
Americans have fueled the research engine by spending much more per capita on 
prescriptions than in any other nation. However, by observing recent trends, this criticism 
of high drug costs will be rapidly changing because the era of big pharmaceutical 
companies is declining very quickly. The good news is that future medications will 
continue to become less expensive as they become available as generic drugs. Consumers 
should see a financial benefit as lower-cost generics replace the expensive elite drug. On 
the negative side, so much of the research and development funding has been cut, thus 
jeopardizing potential new treatments for currently untreatable diseases (Belk, 2014). 
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INSURANCE COMPANIES 
 
 A major contributor to high healthcare costs in the United States is due to the 
presence of hundreds of insurance companies, all with their own set of rules for physician 
reimbursement. Not only does this create a complex network of payment schemes, extra 
paperwork, time demanding tasks, and increased administrative staff, it also accounts for 
the lack of transparency in understanding the actual costs of healthcare. A major problem 
with American healthcare is that it is difficult to identify medical costs. The patient is 
often unaware of costs and oftentimes the doctor does not even know true costs, making 
it very difficult to control the costs. Although a lot of stakeholders have some 
responsibility in contributing to the high cost of healthcare, insurance companies are 
found in the center of the system. They act as the middle-man – receiving payments from 
consumers and moving the money into the healthcare system.  
 While dealing with a plethora of medical knowledge and keeping track of 
patients, physicians often lose track of how much they are actually paid for a given 
service. The most difficult part of starting a medical practice is learning how to deal 
effectively with the insurance companies. In order to get paid by insurance companies, 
physicians have to work with the system, which can be tedious and time consuming.  
 Physician David Belk currently owns a private practice and he claims that 
insurance companies do not want to pay physicians. He states that the longer insurance 
companies can hold on to any dollar they owe, the more they profit. When a doctor starts 
a solo practice, they are almost guaranteed to work several months for free. Although 
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patients are paying premiums to insurance companies, the practice is required to get 
credentialed by the insurance companies before the physicians can actually get paid. Each 
insurance company requires medical practices to fill out detailed paperwork and then 
follow up with multiple phone calls. If they lose the application, or dislike an answer, 
physicians are required to fill out the applications again. Belk claimed that he was not 
paid for any of the services he provided before becoming accredited by insurance 
companies (Belk, 2014). 
 When considering the time demand of dealing with insurance companies, most 
private medical practices hire a billing services team responsible for interacting with 
insurance companies. Physicians provide a summary of the patients they saw along with 
the diagnosis and encounter codes, and the billing service creates billing statements for 
insurance companies and provides the doctor with a monthly check based on what was 
collected. Thus, the current medical payment system has middlemen dealing with 
middlemen, demonstrating how tedious the system has become. Neither patients nor 
physicians truly know how much healthcare can cost. The insurance company essentially 
decides for both sides – premiums for customers and reimbursements for physicians.  
 In general, most doctors and hospitals bill payers for an amount that exceeds what 
they expect to get paid. This tactic has been developed to obtain the maximum amount 
each insurance plan is willing to pay. Since most insurance companies reimburse office 
visits in a narrow pay range, doctor’s offices will bill for 20-30 percent above the 
expected amount to cover their bases and make sure that they actually get paid an 
appropriate amount (Belk, 2014). The problem arises when either the patient does not 
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have insurance or the insurance is denied for some reason. When this happens, the patient 
is responsible for the full amount billed regardless of how much this is above the 
expected insurance reimbursement. This overcharges uninsured people and anyone else 
who was not properly authorized. In other words, if a doctor fails to complete the 
required paper work properly, the patient may be liable for the full cost.  
 The reimbursement rates for office visits can be broken down as follows: The pay 
is different for a new versus an established patient since it takes extra time to get to know 
the new ones. The level of complexity of a patient visit is rated based on the number of 
diagnosis and amount of time spent with a patient. If a procedure is performed, it is added 
to the cost of the visit. A physical exam might pay very well for some insurance plans 
and nothing from others. This is why some doctors have learned to check a patient’s plan 
to see what is covered. Phone calls and authorizations pay nothing. Here are some sample 
rates: Initial visit: $100-$240, Follow up: $60-$175. If the doctor performs a procedure, it 
will be added to the cost. For example: a joint injection will pay $60-$90, abscess 
drainage $100-$130, a female pelvic exam $30-$100 and a physical exam might pay 
$100-$180 (Belk, 2014). 
 HMOs have a very different approach to payment. When doctor gets an HMO 
patient, the doctor gets a monthly stipend of $10-$35 to have them as a patient. Doctors 
receive this paycheck whether they see the patient or not, but they get paid a copay of 
$10-$40 when the patient comes into the office. HMO’s can also pay a doctor extra if the 
doctor provides a specific service. However, the rates for certain procedures change 
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frequently and without warning or explanation. Each month a doctor will get a check 
along with a list of their HMO patients.   
It is clear that even in the narrow field of private practice, there is a range of what 
a doctor gets paid and how they get paid, all depending on the organization of a patient’s 
insurance company. In order to receive a decent amount of payment for their services, 
doctors send a bill to all the insurance companies for an amount that exceeds the actual 
costs of procedures and accept whatever the insurance company chooses to pay for. Over 
the years, physicians have learned to bill for what they know insurance companies will 
pay and to avoid mentioning things that do not get reimbursed. The main problem with 
this approach to billing is that it punishes customers by substantially overcharging them if 
they try to pay out-of-pocket for medical services.   
Other countries also have insurance companies and use similar tools to those used 
in the United States to pay their physicians. However, they have much greater abilities to 
control cost-containment. Some nations control costs by implementing a common fee 
schedule so that hospitals, doctors and health services are paid similar rates for most of 
the patients they see (Kane, 2012). In the United States, how much a health care service 
gets paid depends on the kind of insurance a patient has. This means that health care 
services can choose patients who have an insurance policy that pays them more 
generously than other patients who have lower-paying insurers, such as Medicaid (Kane, 
2012).  
According to Mark Pearson, head of Division on Health Policy at OECD, other 
countries are flexible in responding if they think certain costs are exceeding what they 
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budgeted for. In Japan, if spending in a specific area seems to be growing faster than 
projected, they lower fees for that area (Kane, 2012). Similarly, in France, a public 
service organization closely monitors spending across all kinds of services and if they see 
a particular area is growing faster than they expected (or deem it in the public interest), 
they can intervene by lowering the price for that service (Kane, 2012). These countries 
also supplement lowering fees with other tools. For example, they monitor how many 
generic drugs a physician is prescribing and can send someone from the insurance fund to 
visit physicians’ offices to encourage them to use cheaper generic drugs where 
appropriate. In comparison, United States payment rates are much less flexible. They are 
often statutory and Medicare cannot change the rates without approval by Congress. This 
makes the system very inflexible for cost containment (Kane, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  53 
 
 
LACK OF TRANSPARENCY IN HOSPITAL BILLING 
 
Research at the Dartmouth Institute has documented that there are large variations 
in medical practices across different regions in the United States, which cannot be 
explained by differences in population structure or differences in illness (Kane, 2012). 
They found that the rate of coronary bypass was five times greater in certain hospital 
referral regions in the United States than others. Similarly, regional variations in hip and 
knee replacement are substantial, with the rates four to five times higher in some regions 
compared with others (Kane, 2012). The federal government released prices that 
hospitals charge for 100 of the most common inpatient procedures in 2013. Until then, 
these charges were closely held by facilities that see a competitive advantage in shielding 
their fees from competitors. What the numbers reveal is a health-care system with 
tremendous, seemingly random variation in the costs of services. 
An article from the Washington Post details wide ranging price differences from 
many hospitals in the United States. In the District of Columbia, George Washington 
University’s average bill for a patient on a ventilator was $115,000, while Providence 
Hospital’s average charge for the same service was just under $53,000. For a lower joint 
replacement, George Washington University charged almost $69,000 compared with 
Sibley Memorial Hospital’s average of just under $30,000. Elsewhere, Las Colinas 
Medical Center just outside Dallas billed Medicare, on average, $160,832 for lower joint 
replacements. Five miles away and on the same street, Baylor Medical Center in Irving, 
TX, billed the government an average fee of $42,632. In downtown New York City, two 
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hospitals 63 blocks apart varied by 321 percent in the prices they charged to treat 
complicated cases of asthma or bronchitis (Kliff and Keating, 2013).  
Experts attribute the price disparities in America’s health system to the fact that 
consumers are often unaware of price — and rarely shop for discounts. Although the 
government has collected this information for years, it was housed in a bulky database 
that researchers had to pay to access. Adding another layer of opacity, Medicare and 
private insurance companies typically negotiate lower charges with hospitals. But the 
data shed light on fees that the uninsured could expect to pay. 
“It’s true that Medicare and a lot of private insurers never pay the full charge,” 
said Renee Hsia, an assistant professor at the University of California at San Francisco 
Medical School whose research focuses on price variation. “For uninsured patients, they 
face the full bill. In that sense, the price matters” (Kliff and Keating, 2013). 
The public release of the data is part of an effort by Medicare to increase 
transparency in the health system. Deputy Medicare Administrator Jonathan Blum stated 
that his “mission has shifted to be a trusted source in the marketplace for information. We 
want to provide more clarity and transparency on charge data.” “There’s tremendous 
variation between hospitals,” Blum said. “Geography doesn’t seem to explain it” (Kliff 
and Keating, 2013). 
For-profit hospitals tended to bill Medicare at a 29 percent higher rate, on 
average, than nonprofit or government-owned hospitals (Kliff and Keating, 2013). The 
bills that hospitals submit to Medicare have little relationship with the amount that the 
government actually paid the provider. In many cases, hospitals that submitted higher 
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bills ultimately received lower payments than competitors. Las Colinas, the Texas 
hospital that billed more than $160,000 for a joint replacement, was reimbursed, on 
average, $12,643. Nearby Baylor Medical Center submitted significantly lower charges 
but received a larger reimbursement: $14,202 (Kliff and Keating, 2013). Medicare 
analysts said that teaching hospitals such as Baylor Medical Center receive a higher 
overhead in their payments to cover the costs of treating low-income patients and also to 
fund medical education. 
David Belk also discusses hospital billing on his website, “The True Cost of 
Healthcare,” and provides several examples of how much hospitals charge, how much a 
medical test or procedure should really cost, and how much insurance companies end up 
paying. During a typical annual check-up, physicians perform a physical exam and order 
a few tests such as urine tests and blood tests. Most blood and urine tests are done with 
simple chemicals that have minimal costs. Because labs are pretty efficient at running 
tests, the time commitment of laboratory personnel only cost a couple extra dollars. There 
are a few expensive tests, such as genetic tests, but these are not frequently used in a 
routine screening or diagnostic work ups. The cost of radiology tests can be broken down 
in a similar fashion. There is the original cost of the X-ray machine, CT scanner, or MRI, 
which are usually bought and paid for by the hospital or diagnostic center. In addition, 
there are the costs of maintaining the machinery, paying the staff, preparing certain 
patients for the tests and the radiologist’s fee for reading the X-ray. 
Insurance companies are more aware of the actual costs for these tests and try to 
reimburse the minimum amount that the institution running the test is likely to accept. 
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Routine blood work, for example, only gets paid a few dollars but a CT scan or MRI will 
bring in a few hundred dollars. All tests, procedures, office visits and hospitalizations are 
billed for an amount that exceeds what they expect from any insurance company in order 
to get the maximum amount possible from reimbursement (Figure 9) (Belk, 2014). This 
means that anyone who does not have insurance, or for whom the insurance is denied, has 
to pay five, ten or even twenty times what any insurance company would pay. 
 
 
 
Figure 9. Commonly Ordered Medical Tests, Typical Billing Charges and Reimbursement 
from Medicare and Insurance Companies. Hospitals charge over ten times more for medical 
procedures than the amount they get reimbursed by insurance companies. 
Source: David Belk obtained the billing charges by calling several different hospitals in the San 
Francisco Bay Area. 
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The method of reimbursement for a hospitalization differs substantially for 
different insurance companies, because different payers will reimburse different services. 
Medicare, for example, bases their reimbursement rate solely on the patient’s diagnoses. 
A diagnosis of pneumonia will get a fixed Medicare payment regardless of how long the 
patient stays in the hospital, what tests are ordered, or what treatment is given (Belk, 
2014). Other payers might pay for each individual service. Hospitals have standardized 
their billing to create similar billing statements, despite the particular payer. Thus, the 
best way for hospitals to receive payment is to record anything and everything that might 
be reimbursed by any payer on every bill. 
An insurance company will ignore items it does not cover, but will never add 
anything the hospital leaves out. In other words, there is no penalty for billing too much 
for a service, but not billing enough will cause the hospital to lose money. The only 
potential penalty would be for billing for a service not provided or a diagnosis not 
justified. An insurance company pays the hospital based on pre-negotiated rates, despite 
the amounts listed on hospital bills. The hospital can turn away all patients with that 
insurance, but that would mean turning away a lot of patients. Clearly, the insurance 
companies have become highly influential.  
The process of hospital billing is no longer a normal business transaction, but it 
seems to works as long as it remains between the hospital and the insurance company. 
Hospitals send bills to insurance companies for five to ten times the amount they expect 
and the problem occurs when a patient becomes responsible for the entire amount. Most 
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hospitals have a policy that allows people to negotiate for a lower amount, but most 
people are unaware of these policies and hospitals are not about to advertise them.   
Rather than trying to collect a fair amount for each affordable service directly 
from patients, hospitals turn to the insurance companies for even the most mundane fees. 
Due to the complexity of dealing with insurance companies, each hospital requires a large 
staff of billers, who spend thousands of hours each year filing paperwork and claims for 
reimbursements from insurance companies. This accounts for a large majority of 
administrative costs. Since each patient only brings in a small profit after insurance 
companies have negotiated low prices, so each denial positions hospitals into a financial 
hole. The hospitals solution is to put more pressure on the patients who owe them money 
that was not covered by their insurance.   
One of the biggest problems with medical costs is that the real costs are so well 
hidden that almost no one knows what they are, let alone how to correct the deficits. This 
applies to doctors as much as patients.  Patients can be easily confused into buying drugs 
for far more than they cost, just because their insurance covers it so their doctors 
prescribe it. Doctors also loose some control over their practice since they are forced to 
comply with the system of insurance reimbursement. Even the hospitals are spending 
billions a year on administrative costs to comply with the complex, inefficient, and 
wasteful payment system.   
This system hurts the patients if they are uninsured or denied coverage for a 
particular reason. Hospitals often blame insurance companies to try to justify their 
burdensome pricing. The insurance companies blame the hospitals for over treating and 
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ordering unnecessary procedures. This system is frustrating for all parties – insurance 
companies, hospitals, private practices, nursing homes, and unfortunate patients who end 
up with overpriced medical bills. 
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ADMINISTRATIVE COSTS 
 
The discussion of lack of transparency in the medical billing system dealing with 
numerous insurance companies with different policies lead to the issue of excessive 
administrative costs in the United States. Administrators have become indispensable to 
modern health care. Their tasks include ensuring that supplies are on hand, that records 
are filed, and that medical staff receives payment (Woolhandler et al., 2003). However, 
some regard much of administration as superfluous. They believe that it caters to the 
complexity of the payment system rather than anything clinically related. Physician 
private practices, which are more common in the United States, incur substantial costs in 
time and labor when interacting with multiple insurance plans about claims, coverage, 
and billing for patient care and prescription drugs (Morra et al., 2011). 
Administrative Costs: United States Versus Canada 
Several studies have compared the administrative costs in the United States with 
that of Canada. The clear consensus is that much higher administrative spending in the 
United States relative to that in Canada does not improve care outcomes. According to a 
2003 article by Woolhandler et al. in the New England Journal of Medicine, several 
factors augment U.S. administrative costs compared to Canada. Private insurers, which 
have high overhead costs, have a larger role in the United States than in Canada. The 
interaction between health insurance plans and physician practices are one prominent 
component of administrative costs. Physician practices in the United States must interact 
with many health plans in the U.S. multipayer system. Furthermore, these interactions 
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increase with each plans’ attempt to “manage care.” Insurance companies will require 
prior authorizations for many specialists, imaging tests, and hospital services. Each health 
plan offers many different insurance products to consumers, and each may have its own 
list of approved drugs; prior authorization requirements; and rules for billing, submitting 
claims, and adjudication (Morra et al., 2011). In contrast, Canadian physicians generally 
interact with a single payer, and thus Canadian hospitals are subject to fewer managed 
care requirements. The American system with multiple insurers is intrinsically costlier 
than a single-payer system like that found in Canada. 
In America’s multipayer system, providers are forced to determine a patient’s 
eligibility for certain treatments and they must to keep track of the various copayments, 
referral networks, and approval requirements specific to each insurance company. On the 
other hand, Canadian physicians send virtually all bills to a single insurer. Canadian 
hospitals and government authorities negotiate an annual budget based on past budgets, 
clinical performance, and projected changes in services to create a global-budget system 
(Woolhandler et al., 2003). Hospitals receive periodic lump-sum payments – for example, 
1/12 of the annual amount each month. Canada’s global-budget healthcare system has 
eliminated most billing discrepancies and minimized internal costs for accounting, since 
charges do not need to be attributed to individual patients and insurers.  
These costs should be balanced against possible benefits generated by such a 
system—for example, benefits that may arise from competition, innovation, and choice 
among insurance products. Prior authorization requirements increase administrative costs 
for physicians and health plans but may reduce the amount of inappropriate care 
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provided; savings and increased quality generated by reducing inappropriate care should 
be matched against the costs of prior authorization. Currently, no reliable estimates of 
these savings exist (Morra et al., 2011). 
A more recent study from the Health Affairs Journal conducted surveys with 
physicians and administrators in the province of Ontario, Canada, and compared the 
results with a national companion survey in the United States. These surveys contained 
questions about how much time medical personnel and administrative staff spent 
interacting with payers. Physician practices in Ontario are estimated to spend $22,205 per 
physician per year interacting with Canada’s single-payer agency. This accounts for only 
27 percent of the $82,975 per physician per year spent in the United States (Morra et al., 
2011). In addition, American nursing staff and medical assistants spent 20.6 hours per 
physician per week interacting with health plans, which was nearly ten times that of their 
Ontario counterparts (Morra et al., 2011). If hospitals and providers in the United States 
had administrative costs similar to those of Ontario physicians, the total savings would be 
approximately $27.6 billion per year (Morra et al., 2011). The notable difference between 
the United States and Ontario is that non-physician staff members in the United States 
spend large amounts of time on billing and obtaining prior authorizations. Many U.S. 
health care leaders interviewed for this study agree that interactions between physician 
practices and health plans could be performed much more efficiently. 
Propositions to Reduce Administrative Costs in the United States 
Recently, specific recommendations—with a good deal of overlap—have come 
from the Institute of Medicine, the Massachusetts General Physicians Organization, 
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UnitedHealth Group, and the broad-based Healthcare Administrative Simplification 
Coalition (Morra et al., 2011). Key recommendations include the following: -­‐ Creating common, possibly mandatory standards for interactions such as billing, 
claims payment, prior authorization, etc.  -­‐ Making all standard interactions electronic, rather than through multiple phone 
calls or snail mail.  -­‐ Using a single credentialing process for all insurance companies to avoid 
excessive paperwork and potential duplications. -­‐ Using a single quality measurement process to decrease complexity in what 
insurance companies will and will not cover. -­‐ Using automated verification at the point of care of patient eligibility for health 
insurance benefits, opposed to potentially subjective decisions made by insurance 
companies. 
Some progress is being made. The Council for Affordable Quality Healthcare 
makes it possible for physicians to submit materials for credentialing electronically 
(Morra et al., 2011). Health plans and hospitals can use these materials to credential 
physicians, avoiding the costs of submitting materials multiple times and in different 
formats. Section 1104 of the Affordable Care Act instructs the secretary of health and 
human services to take steps to simplify interactions between providers and health plans 
(Morra et al., 2011). The reform bill also supports the implementation of new payment 
methods such as bundled payments and increased emphasis on pay-for-performance, as 
well as new forms of organization such as Accountable Care Organizations. 
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In the short run, these new reforms and organization of the payment system are 
likely to increase the administrative burden for physicians and health plans. In the longer 
term, these new reforms should move the system away from fee-for-service payment and 
thus reduce the administrative costs involved in producing, reviewing, and processing 
claims for each service provided. In addition, accountable care organizations and 
organizations that receive bundled payments would have incentives to be cost-conscious, 
so the heavy costs associated with prior authorizations and formularies would probably 
be reduced. 
International Comparison of Healthcare Administrative Costs 
Although there is a copious amount of information comparing Canadian and 
American healthcare administrative costs, a more recent article by Himmelstein et al. 
compares administrative costs amongst developed countries. They assembled a team of 
international health policy experts to analyze the hospital administrative costs across 
eight nations: Canada, England, Scotland, Wales, France, Germany, the Netherlands, and 
the United States. To assess the impact of a range of payment strategies, they chose 
nations with widely varying health care systems. Three of the nations—England, 
Scotland, and Wales—are within the United Kingdom. Each has a public National Health 
Service (NHS) funded by taxes, but the three systems vary in their hospital funding. 
Canada has a single-payer public insurance system in each province. France has a system 
analogous to a single-payer social insurance model. However, payments are funneled 
through several supposedly separate insurance funds. Germany and the Netherlands have 
compulsory, multipayer social insurance systems, but the Netherlands is transitioning to a 
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market-based payment system. The United States has a largely private, multipayer health 
care system (Himmelstein et al., 2014). 
In all nations, hospital administrators must obtain and coordinate the facilities, 
supplies, and personnel needed for good care. In nations where administrators have few 
responsibilities beyond these logistical matters, administration seems to require about 12 
percent of hospital expenditures. Unsurprisingly administration costs were the highest in 
the United States, at 25.3 percent. This was more than twice the percentages for Canada 
and Scotland, which spent the least on administration. The next highest nations were the 
Netherlands (19.8 percent) and England (15.5 percent), both of which are transitioning to 
market-oriented payment systems similar to the U.S. (Himmelstein et al., 2014). 
Garnering operating funds requires little administrative work in nations such as 
Canada, Scotland, and Wales, where hospitals receive global, lump-sum budgets. In 
contrast, per patient billing requires additional clerical and management personnel and 
special-purpose IT systems. This is true even in countries—such as France and 
Germany—where payment rates, documentation, and billing procedures are uniform. 
Billing is even more complex in nations where each hospital must bargain over payment 
rates with multiple payers, whose documentation requirements and billing procedures 
often vary, as is the case in the United States and the Netherlands  (Himmelstein et al., 
2014). 
Differences in how hospitals obtain capital funds also appear to affect 
administrative costs. The combination of direct government grants for capital with 
separate global operating budgets—as in Scotland and Canada—are associated with the 
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lowest administrative costs. Hospitals in France and Germany, where direct government 
grants account for a substantial share of hospital capital funding, have relatively low 
administrative costs despite per patient billing. Administration is costliest in nations 
where surpluses from day-to-day operations are the main source of hospital capital funds: 
the United States and, increasingly, the Netherlands and England. In such health care 
systems, the need to accumulate capital funds for modernization and expansion stimulates 
administrators to undertake the additional work that is needed to identify and pursue 
profit opportunities. This entrepreneurial incentive rewards hospitals that cut unnecessary 
operating costs and thereby improves efficiency. However, it can also reward hospitals 
for devoting resources to activities that decrease efficiency, such as advertising; 
exaggerating the severity of patients’ illnesses in order bill for more procedures; and 
cherry-picking profitable patients, physicians and services while avoiding unprofitable 
ones  (Himmelstein et al., 2014). 
Compared to other U.S. hospitals, for-profit institutions spend less on clinical 
personnel such as nurses but provide costlier care. Similarly, in Germany for-profit 
hospitals do not appear to be more efficient than other hospitals. The divergence between 
Scotland and England is also instructive. Administrative costs are low in Scotland, where 
hospitals do not bill for individual patients and capital projects are funded by direct 
government grants—which leaves administrators little leeway for financial 
entrepreneurship. In contrast, the administration share of costs is higher and rising in 
England, where per patient billing has largely replaced global hospital budgets and recent 
market-based reforms encourage entrepreneurialism.  
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Hospital administrative costs appear to be driven by the complexity of the 
reimbursement system and the mode of capital funding. Overall, there is no evidence that 
the high administrative costs in the United States translate into superior care 
(Himmelstein et al., 2014). Reducing U.S. per capita spending for hospital administration 
to Scottish or Canadian levels would have saved more than $150 billion in 2011 
Himmelstein et al., 2014). This study suggests that the reduction of U.S. administrative 
costs would best be accomplished through the use of a simpler and less market-oriented 
payment scheme. 
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SOCIAL DETERMINANTS OF HEALTH 
 
Thus far, the focus has been elucidating the costs involved in healthcare, but now 
the discussion shifts to healthcare outcomes and how to improve overall health in the 
United States. In “The American Healthcare Paradox,” Elizabeth Bradley and Lauren 
Taylor propose a new approach to understanding the American failure to achieve top-
rated health outcomes despite its enormous investment in health care (Bradley & Taylor, 
2013). They first take a closer look at what is being measured in international health 
reports and what is not considered. The OECD defines health expenditure as “the 
spending for the final consumption of all health goods and services plus the capital 
investment in health care infrastructure. These expenditures include curative care, 
rehabilitative care, long term care, mental health care, ancillary services (diagnostic 
imaging, laboratory tests, patient transport), outpatient medical goods, prevention and 
public health services, health administration, public health insurance, new healthcare 
building and facilities, health education and training, and health research and 
development” (OECD, 2015). 
What is NOT included as health care spending is social services and 
environmental wellbeing, which both play considerable roles in affecting health 
outcomes.  These social factors include housing, nutrition, education, environmental 
conditions, exercise incentive and unemployment support. Given the WHO definition of 
health as “a state of complete physical, mental and social well-being” one can see how 
health spending limited to what the OECD measures might result in an incomplete 
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picture. When looking at inpatient populations in hospitals, most are from disadvantaged 
backgrounds who are much more likely to experience serious illnesses and premature 
death. Poverty, social isolation, lack of control in one’s life and work, psychological 
stresses, risky lifestyle choices, food insecurity, lack of educational support and housing, 
and job insecurity have all been shown to compromise health (Bradley and Taylor, 2013). 
According to the OECD definition of health spending, the United States is 
spending an exorbitant amount. However, the United States is not spending as much as 
other industrialized countries on fortifying social services that help maintain healthy 
lifestyles. The US spends about 10-13% of its GDP on Social Services whereas countries 
like France, Sweden, Austria, Switzerland, Denmark, and Italy spend about 20% of its 
GDP on Social Services (Figure 10) (OECD, 2009). According to Figure 9, the United 
States no longer spends the largest percentage of GDP if spending for heathcare and 
social services are combined. With this new scale of percent GDP for health spending, 
the US now ranks 13th among OECD countries (Bradley and Taylor, 2013). Thus, the 
United States is not necessarily spending more than everyone else. Americans spend 
more on healthcare to compensate for what they are not paying in social services—and 
the tradeoff is not good for the country’s health. 
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Figure 10. Total Health Service and Social Service Expenditures for OECD Countries 
(2005). In OECD countries, for every $1 spend on healthcare, $2 is spend on social serivces. In 
the U.S., for every $1 spend on health care, 55 cents is spend on social services.  
Source: OECD Health Data 2009 
 
Bradley and Taylor’s 2010 study found that Countries with high healthcare 
spending relative to social services spending had significantly lower life expectancy and 
higher rates of infant mortality and low birth weights (Bradley et al., 2011). In terms of 
social conditions, America allows more children to remain in poverty than any other 
industrialized nation, it offers unmarried mothers with less help with daily needs, it 
provides fewer citizens with public housing, and it spends less on job training and job 
creation than its European counterparts (Bradley and Taylor, 2013). Why is the United 
States social services sector so underdeveloped compared to other countries? Among 
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political science scholars, America is generally viewed as lagging behind when it comes 
to its social welfare policies. In addition to being unwilling to provide federally funded 
health insurance, the United States government has been even slower to fund social 
welfare programs such as unemployment insurance and family allowances. The reasons 
for this can be found by looking at America’s history and ideologies. 
America was built on individualism and the belief that hard work will allow 
anyone to climb the socioeconomic ladder from rags to riches and achieve the American 
Dream. Idleness was perceived as sinful so handouts should be provided sparingly. Even 
today, many Americans scoff at increased taxations and government welfare programs 
because they believe that public aid will weaken an individuals’ work ethic. Since the 
formation of states, there has been perpetual tension between the autonomy of the states 
and the authority of the federal government. As a result, the United States did not develop 
a unifying law for social welfare like European nations (Germany, Great Britain, etc.). 
Instead, they depended on state and local governments to create programs that would best 
suit their populations. Today, social welfare programs in America remain highly 
decentralized with significant variation in benefit levels across the state. Even though 
financing for social programs are received through taxpayer dollars, they are distributed 
as grants to a plethora of private nonprofit agencies and employers.  
The U.S. health care sector is suffering severely from its inadequate social 
services sector. Physicians are increasingly aware that unmet social needs contribute 
significantly to worse health for Americans and their reports highlight the growing 
negative influence of the social environment on people’s health. Physicians believe that 
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one out of seven prescriptions they write should address social needs including fitness, 
nutritional food, employment assistance, education, and housing (Bradley and Taylor, 
2013).  
Although the U.S. does not have a comprehensive social service sector, they do 
boast an expansive emergency medicine system. A lot of cases that do not require 
medical attention are treated in the Emergency Department (ED) as a last resort (Bradley 
and Taylor, 2013). For example, emergency departments may see frequent visits from an 
inebriated homeless man or the lonely elderly who grow more anxious about their health 
as they age. The ED will admit patients and deal with temporary problems, but they do 
not perform follow-ups nor do they spend more than 15 minutes with patients on average. 
The ED has become an extremely expensive, but rather routine route for care for 
vulnerable populations (Bradley and Taylor, 2013).  
Front line medical personnel are stretched to respond to patient concerns because 
they are not equipped with the proper resources. Providers of health care, whether 
physicians, nurses, or administrators, say that time has become a scarce resource as they 
fight a tide of paperwork and bureaucracy of administrative, legal, and financial realities. 
Even primary care physicians, who are expected to collect a strong patient history and 
assess current lifestyle, claim to experience difficulties in effectively treating their 
patients. Recent evidence suggests that the average time a patient spends with the 
physician at a primary care visit is less than 15 minutes and nearly half of a primary care 
physician’s time is spent on documentation and follow-up, outside the examination room 
without the patient present (Gottschalk and Flocke, 2005). 
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Nurses also experience inadequate time to address both the patient’s medical 
needs, which they are trained to do, and their social needs, which they cannot avoid. For 
example, a pediatric nurse in Boston describes taxing interactions with drug-addicted 
mothers and their babies. Nurses end up with the responsibility of managing a 
relationship with the mothers, prompting them to feed their babies according to schedule, 
holding their hand through social work consultations, and teaching them how to manage 
the stresses of caring for a newborn, often with little lasting impact (Bradley and Taylor, 
2013). Time spent on these activities result in enormous opportunity costs for nurses 
highly trained in medical care and less prepared for social work and counseling care they 
end up dealing with.  
The need for a more holistic approach to caring for people’s health and social 
needs is widely acknowledged but requires professional collaboration between health and 
social services. Physicians, social workers and others at the front line fully acknowledge 
the importance of recognizing a patient’s full range of needs including physical, 
emotional, social and even spiritual dimensions of health. A partnership between health 
professionals and social service workers is lacking or absent in many hospitals. Hospitals 
run 24/7 while social service workers have regular 9-5 hours Monday through Friday 
where there just is not enough time to deal with all the social issues experienced by 
patients. Effective coordination between the health and social service sectors is rare, and 
the causes of this lack in partnership are many.  
First of all, there is an apparent lack of resources in the social services sector 
itself. As a result of underfunding and a lack of rigorous training, social service programs 
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are understaffed and unable to cover a large client base with their little time. Secondly, 
differences in professional culture between doctors and social workers create a barrier. 
Their distinct mission statements and models of care can led to conflicts and personal 
disagreements. The ethos in social services is to meet the client where he or she is and to 
assess the client’s motivation to change. In contrast, many heath care entities have a more 
narrowly defined mission to provide medical treatment meant to address specific illnesses 
(Bradley and Taylor, 2013). In addition, concerns over privacy and technical barriers to 
information sharing also prohibit interdisciplinary collaboration between sectors.  
A third formidable barrier between healthcare and social services is the lack of 
financial incentives to do so. Health care providers are generally rewarded for increased 
numbers of patients treated and the complexity of medical care provided. If social service 
workers can adequately take care of nonmedical needs so people no longer need to seek 
medical attention, this coordination may not be in the physician’s financial interest. The 
executive director of a health and social service organization describes such a situation, 
“At [hospital name], we had a super successful outpatient diabetes center; so successful 
that it reduced the number of hospitalization, amputation, etc., dramatically. So the 
hospital shut it down because it lost them money. In a country like the United States in 
which there is limited central management and every industry (healthcare, social 
services) stand on its own, it is extremely difficult to get one organization to voluntarily 
collaborate with another that has the potential to put the first one out of business” 
(Bradley and Taylor, 2013). Efforts at holistic medicine continue to be undermined by 
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fears among health care organizations that successful collaboration with social services 
may diminish their potential for revenue.  
Learning from Scandinavian Nations 
Scandinavia is often used as an example of a national system that does integrate 
health and social services. Scandinavia also leads in achieving superior health outcomes 
for its people. The United States usually looks to culturally familiar counties like Canada 
or the United Kingdom for more successful health care models. While these countries do 
have moderately better health outcomes, Scandinavian countries, such as Sweden, 
Denmark, and Norway, truly outperform the United States. However, these countries 
have social democracies, which is a political ideology a lot of Americans are vehemently 
against. In terms of health outcomes, these Scandinavian countries are global leaders 
(Table 9) (OECD, 2007).  
 
Table 9. Comparison of Health Outcomes Between United States and Scandinavian 
Countries. Scandinavian countries generally have better health outcomes than the United States, 
the United Kingdom, and Canada. Source: OECD Health Data 2007 
 
 Infant	  Mortality	  
(Deaths	  per	  1,000	  
live	  births)	  
Life	  Expectancy	  
(Years)	  
Low	  Birth	  Weight	  
(%	  of	  total	  Live	  
Births)	  
Maternal	  Mortality	  
(Deaths	  per	  100,000	  
live	  births)	  
Sweden	   2.5	   81.0	   4.1	   1.9	  
Denmark	   4.0	   78.4	   6.7	   14.0	  
Norway	   3.1	   80.6	   5.1	   6.8	  
	   	   	   	   	  
Canada	   5.1	   80.7	   6.0	   6.5	  
United	  Kingdom	   4.8	   79.7	   7.1	   7.1	  
	   	   	   	   	  
United	  States	   6.8	   77.9	   8.2	   12.7	  
 
The Scandinavian countries have publicly financed health insurance systems that 
cover 100% of citizens. In addition, these Scandinavian countries spend about half of 
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what the United States spends per capita on health care. The Scandinavian approach has 
consistently achieved the best health outcomes in the world at a reasonable cost for the 
last decade (OECD, 2011).  
A major and fundamental difference between American and Scandinavian 
societies is their view on government function. Scandinavians place strong emphasis on 
the value of universalism and they believe services should be available to all people 
(Bradley and Taylor, 2011). People in Scandinavia are more likely to argue that 
government ownership of business and industry should be increased and that government 
should take more responsibility to provide for everyone as needed. This Scandinavian 
enthusiasm for an expansive government in multiple domains of their public and private 
lives is likely to be unpopular among many Americans. Americans typically desire 
independence and value the hard work and success of the individual. Even if Americans 
can accept that others in their country need support, substantial discomfort is observed 
when sacrificing one’s own hard-earned income to support others. In contrast, many 
Scandinavians accept taxation as a necessary insurance to their own vulnerability. They 
believe that the taxes they pay are going to fund programs for people who need them, 
which might one day include their own family, or even themselves (Bradley and Taylor, 
2013). 
In Denmark, they do not share the same American fear that people can become 
dependent on social welfare programs and therefore stop working hard (Bradley and 
Taylor, 2013). Their social welfare system is based on the idea that every citizen has a 
right to a minimum income, but they also have a duty to work. If a citizen of Denmark 
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cannot find a job, the municipality will provide them with a job. These jobs often 
involved picking weeds from public parks, working in supermarkets, cleaning, and other 
labor-intensive work. Those who are not able to work due to sickness or old age have no 
duties. The level of welfare also has to be lower than the entry-level wage. If the citizens 
do not show up for work, they cannot get paid (Bradley and Taylor, 2013). The work 
offered by the municipality is usually unattractive which can encourage people to keep 
looking for higher paying jobs. 
Income Inequality in the United States 
The United States now tops most of their Western European and Scandinavian 
peers in income inequality and this widening gap could be attributed to the deficiencies in 
their social services sector. Today in the United States, the top quintile controls 84 
percent and the bottom quintile controls about 1 percent and this gap continues to widen 
(Norton and Ariely, 2011). The equivalent ratio in Sweden was 3.5 to 1. Income 
inequality such as that seen in the United States has been linked to increased violence and 
distrust, poorer health, elevated anxiety, and poorer economic growth (Weede, 1981). 
Published studies show inequality as a major driver of a number of “social corrosions,” 
including lack of community life, violence, drugs, obesity, mental illness, and ill health. 
(Weede, 1981). 
 Scandinavian citizens pay 50 to 60 percent of their income to taxes, which would 
be intolerable to many U.S. citizens. Americans believe that the concept of redistributive 
justice may be unnecessary and even detrimental to the country’s economic well-being. 
They have developed the widespread belief that people are in control of their life 
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direction and can reach their goals through hard work and discipline. However, the data 
does not support this ideal vision of social mobility. Of the children born in the United 
States to a family in the bottom quartile, 40 percent stay in the bottom quartile and 30 
percent move up one quartile (Delgado, 2007). While 40 percent of the offspring born to 
families in the lowest quintile stay in the lowest quintile in the US, the corresponding 
percentages are much smaller in Sweden, Denmark, and Norway (26, 25, and 28 percent, 
respectively). Thus, even as Americans may believe that people can pull themselves up in 
a democratic, free-market, capitalist society, the data reveals a “stickier” lower class that 
generally retains its constituents for generations (Delgado, 2007). 
Every nations approach to health care must balance funding for physicians, 
hospitals, pharmaceuticals, and other health care enterprises. What Scandinavian 
governments do better than most is focus on balancing upstream work to keep people 
healthy, with downstream work of medical care for people after they have fallen to 
disease. In accepting a broad view of the upstream determinants of health, Scandinavian 
policies allow social and medical services to be planned and managed together in many 
cases. In recent years, Americans have also started to shift their views and many 
scientists have arrived at a similar conclusion that social conditions are equally as 
important for health outcomes as a healthcare system. The crucial need for attention to 
broader determinants of health is well documented, but the funding shift required to 
implement such a vision remains elusive in a political landscape characterized by diffuse 
power and uncooperative bipartisanships.   
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In summary, Scandinavia offers several lessons that the United States can learn 
from while addressing high spending and limited health outcomes. First of all, the 
responsibility for the health of the population should be delegated to locally elected 
government. This would enable coordinated budget allocation based on a communities 
needs and feedback. Secondly, the acceptance that health is determined by more than 
medical services is fundamental to shaping a different approach to health care.  There 
needs to be a willingness to work closely and to streamline the interaction between health 
and social service providers. In addition, this would most likely involve a shift in funding 
from healthcare to the social service sector to create a more efficient and effective 
approach to holistic health.  
Although Scandinavia displays much strength when discussing healthcare, they 
still have their own problems (Bergman, 1998). Waiting times for government services 
can be long by American standards. Wait times for specialty care, and emergency care 
are substantially longer in Sweden than in the United States (OECD data, 2011). In 
addition, healthcare expenditures are increasing everywhere, which requires greater 
taxation, which can be challenging for sustaining their government-based model. 
What we learn from Scandinavian countries are not instructions of how the United 
States should move forward in terms of reform, but rather a broadened perspective and 
new ideas for approaching current healthcare challenges. Health policy in the United has 
thus far focused on curtailing spending, expanding access, and improving quality of 
healthcare services, but there is always room for continued progress. Investigating 
Scandinavian approaches highlights the cultural constructs that contribute to better health 
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outcomes including greater income equality, government (federal and local) 
accountability, conception of health, and integration of social services.  
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FUTURE OF HEALTHCARE/CONCLUSION 
 
In conclusion, the United States outspends every country on every aspect of its 
healthcare system, yet their health outcomes have fallen behind most industrialized 
nations. However, America recognizes that there are problems with the healthcare system 
and has begun implementing large scale reforms through programs such as the 
Affordable Care Act that was signed into legislation in 2010.  
Why are Healthcare Costs so High in the United States? 
Financially, the biggest issues seem to relate back to the complexity of the 
payment schemes developed by insurance companies, which have resulted in the lack of 
transparency in hospital billing statements. This method of reimbursement pits insurance 
companies against hospitals and physicians in a war that sabotages patients when they 
must pay out-of-pocket for medical care. The exorbitant medical bills created for the 
purpose of garnering reimbursements from frugal insurance companies is completely 
unaffordable to the average patient. Currently, switching to a single payer model with 
global hospital budgets like those seen in Canada is highly unfeasible in the United 
States. Insurance giants and their lawyers and lobbyists would fight against such drastic 
reform and the American people would not support such a substantial increase in taxes 
required for a government-regulated system. America’s market based economy drives 
competition between insurance companies to develop innovative plans to attract clients 
and attempt to keep healthcare costs expenditures low. However, these unique plans that 
each insurance company develops creates difficulties in standardizing payments and thus 
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creates more work and headaches for hospital administrators. Eventually this payment 
fiasco needs to be simplified and the cost of healthcare needs to be more transparent for 
the purposes of efficiency.  
Drug prices are another major contributor to cost and are clearly more expensive 
in the United States than in other countries. Pharmaceutical companies determine their 
drug prices and generic drugs can only be created when a drug’s patent expires. Again, 
governments in European countries can set caps and regulate drug prices, which is not 
something the United States government can lawfully control. Nevertheless, drug prices 
are dropping rapidly in the United States as pharmaceutical company drug patents are 
beginning to expire and cheaper generic drugs are being made available in the market. In 
addition, non-profit and government groups are pressuring pharmaceutical companies to 
lower their drug prices. Fortunately for consumers (but unfortunately for pharmaceutical 
companies), the costs of drug prices will continue to drop in the near future.   
Finally, the third major driver of cost in the American healthcare system is the 
higher cost of procedures as well as the increased quantity of medical tests and 
procedures being order – whether they are necessary or not. The United States is 
unquestionably a leader in research and development, so they have the greatest access to 
cutting edge medical technologies. Once private and public insurance companies approve 
these expensive technologies for reimbursement, the frequency of their use increases 
without necessarily considering its cost-effectiveness. In addition, physicians are also 
taught to order comprehensive testing in order to avoid being sued for medical 
malpractice. It does not help that they get paid for each procedure separately, which 
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creates a financial incentive for physicians to order more tests and procedures. In the 
future, medical facilities will most likely change their fee-for-service payment schemes to 
managed care bundled packages which reward for quality of care rather than quantity of 
care. This new method for payments may help the healthcare system avoid over testing, 
unnecessary procedures, and high-tech interventions.  
Why are Healthcare Outcomes so Poor in the United States? 
A major reason that the United States ranks poorly in health outcomes like life 
expectancy, infant mortality, and low birth weight, is because its primary care sector is 
blatantly lacking. The United States is very focused on specialty care so its health 
outcomes for cancer treatment are quite high and they perform more surgeries than other 
countries. Most medical students are not attracted to practicing family care in the future 
and most hope to specialize their career opposed to being a general practitioner. Every 
year primary care spots do not get filled in the National Residency Match process. Due to 
the underdevelopment of the primary care sector, the United States ends up with costly 
hospital admissions for chronic conditions, which add financial burden to the health 
system. Costly hospital admissions have been high particularly for asthma and chronic 
obstructive pulmonary disease even though such admissions could potentially be avoided 
if appropriate care is provided in primary care settings (OECD 2011). This obvious 
problem of a shortage of primary care doctors will continue to grow as the Affordable 
Care Act covers more people with health insurance, but they will not actually be able to 
find a physician.  
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Poor health outcomes can also be attributed to an underfunded social services 
sector. By looking to examples set by Scandinavian countries, it is clear that their 
socialist views of taking care of their citizens in a holistic manner lead to better health 
outcomes. If a society can alleviate stresses cause by food insecurity, housing problems, 
unemployment, healthcare access, and other environmental conditions, the health and 
happiness of their citizens will undoubtedly improve. American physicians are also 
coming to the realization that they can no longer practice disease-centered medicine so 
medical school curriculums are shifting to teach students patient-centered medicine. This 
holistic approach to medicine allows doctors to better understand the upstream 
determinants of health and to treat patients as a whole instead of just as a disease. 
However, doctors and nurses are limited when dealing with social issues because they are 
medically trained. They require a robust support system of social workers that can 
provide the proper resources for patients at home, outside of a medical setting.  
Although creating a team to take care of a patient’s social needs might be time 
demanding, it does not necessarily need to be extremely expensive. Hospitals are often 
located near colleges and universities with a plethora of students looking for volunteer 
opportunities. With proper and intensive training, these volunteers could help provide 
patients find the resources they need to maintain a healthier lifestyle – whether its help 
obtaining nutritional food, housing resources, navigating a public transportation system, 
looking for jobs etc. Instead of relying on the government to develop national social 
programs, it is probably more effective to develop local programs to meet the specific 
needs of a community.   
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What are the current impacts of reforms such as the Accountable Care Act on the 
United States healthcare system? 
The United States understands that their current health system is unsustainable 
and lagging behind other countries, which has led to major efforts for reform. President 
Obama’s Affordable Care Act was signed into legislation in 2010. At its most basic level, 
the ACA was intended to reduce the number of Americans without health insurance. 
Measured against that goal, it has made considerable progress. A series of private sector 
surveys and a government reports have reached the same basic estimates: The number of 
Americans who have gained health insurance in the past year is around 8 to 11 million 
people. 
Of that total, more than half are newly insured through Medicaid, especially in the 
states that broadened eligibility for the program. The rest enrolled in private health plans 
through the new online insurance marketplaces. This online marketplace forces insurance 
companies to be more transparent. It gathers insurances plans in one place for buyers to 
compare costs and benefits. It also requires insurance plans to present themselves in a 
cohesive manner so consumers can understand their benefits. In order to provide 
widespread coverage, the ACA has three mandates for insurance companies: they cannot 
deny policies to people with pre-existing conditions, they cannot drop customers who get 
too sick, and they must allow students to stay on their parents insurance until they reach 
the age of 26.  
Health care remains one of the few industries in America that rely on paper 
records, so the Affordable Care Act will institute a series of changes to standardize 
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billing. New requirements include mandating health plans to begin adopting and 
implementing secure and confidential electronic exchange of health information. Using 
electronic health records will reduce paperwork and administrative burdens, cut costs, 
reduce medical errors and most importantly, improve the quality of care. 
The ACA is also creating a “Bundle Payment” system opposed to the previous 
fee-for-service model. The law establishes a national pilot program to encourage 
hospitals, doctors, and other providers to work together to improve the coordination and 
quality of patient care. Under this bundling method, hospitals, doctors, and providers are 
paid a flat rate for an episode of care rather than the current fragmented system where 
each service or test are billed separately to Medicare. For example, instead of a surgical 
procedure generating multiple claims from multiple providers, the entire team is 
compensated with a “bundled” payment that provides incentives to deliver health care 
services more efficiently while maintaining or improving quality of care.  It aligns the 
incentives of those delivering care, and savings are shared between providers and the 
Medicare program.  
The ACA also encourages cooperative collaboration amongst medical facilities to 
offer better quality care. The new law provides incentives for physicians, hospitals, 
nursing homes, and other care providers to join together to form integrated health systems 
known as “Accountable Care Organizations.” These groups allow doctors to better 
coordinate patient care and improve the quality of care, help prevent disease and illness, 
reduce unnecessary hospital admissions, and avoid unnecessary duplication of services. If 
Accountable Care Organizations provide high quality care and reduce costs to the health 
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care system, they can keep some of the money that they have helped save for the 
Medicare program. These innovative Accountable Care Organizations will be carefully 
studied on a relatively small scale, before it can be scaled up nationally.  
Although the Affordable Care Act was initially met with a substantial amount of 
controversy and many opposed the idea of universal healthcare in America, it is apparent 
that this new legislation has succeeded in implementing some huge improvements to the 
United States Healthcare System. The goals of the bill include increasing access to 
healthcare, standardizing and increasing the transparency of insurance companies, 
creating more efficient and less wasteful methods of delivering care, and a variety of 
other improvements to help regulate costs and improve health outcomes. Although 
physicians and insurance companies were initially skeptical about the implementation of 
this bill, it has clearly proved to be a step in the right direction. 
What are the Next steps to Help Progress and Improve America’s Healthcare 
System? 
The next steps for the United States health system include continuously 
researching and monitoring the recent changes and reforms. The whole world is watching 
as America has created theses Accountable Care Organizations and Medical Homes to 
offer better-coordinated care and more efficient care. Since these health models are only 
being implemented in recent years, both public programs and private research groups will 
be closely monitoring their benefits and downfalls, their cost-effectiveness and their 
ability to improve health outcomes while increasing patient satisfaction, and how they 
compare to the more traditional health systems. These programs will also receive bundle 
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payments through Medicaid, which will help simplify the currently complex payment 
schemes. If these programs prove to be successful, their methods will be adopted and 
scaled up nationally.  
 Another important factor to consider is investing in the education of the younger 
generations. Physicians, nurses, physician’s assistants, dentists, public health officials, 
and business administrators should learn about the current state of America’s healthcare 
system during their professional education. Teaching these topics in these professional 
graduate schools will not only allow for a more well-rounded education, but also for 
better prepared students that are aware of the systems they are going into. These students 
are the future of America’s healthcare system and they need to be aware of all the current 
problems before they can practice conscious medicine. These students are going to be 
tomorrow’s leaders that work together to keep improving the United States healthcare 
system and they need to collaborate not only to provide the best quality of care for their 
individual patients, but also to understand how to promote public health agendas and 
work with administrators and insurance companies to create a more harmonious 
environment.  
National and State regulatory committees can create a set guidelines to help State 
and Local municipalities to implement wiser, more efficient, and more cost effective 
methods of delivering care. Organizations will more likely respond better to constructive 
suggestions rather than government mandates. Although many complain about how 
tedious the American healthcare system has become, the U.S. is continually assessing 
their system, comparing it to other countries, and reforming their policies to progress in a 
  89 
positive direction. Slowly, but surely, with investments in the younger generations and 
continual reassessments of reforms, America has the potential to transform its healthcare 
system to be more cost effective and achieve better health outcomes.  
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